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ABSTRACT  
   
Background: Twenty-four hour urinary sucrose and fructose (24uSF) has been 
developed as a dietary biomarker for total sugars intake.  Collection of 24-h urine is 
associated with high costs and heavy participant burden, while collection of spot urine 
samples can be easily implemented in research protocols.  The aim of this thesis is to 
investigate the utility of uSF biomarker measured in spot urine. Methods: 15 participants 
age 22 to 49 years completed a 15-day feeding study in which they consumed their usual 
diet under controlled conditions, and recorded the time each meal was consumed.  Two 
nonconsecutive 24-hour urines, where each urine void was collected in a separate 
container, were collected.  Four timed voids (morning, afternoon, evening, and next day) 
were identified based on time of void and meal time.  Urine samples were measured for 
sucrose, fructose and creatinine.  Variability of uSF excretion was assessed by coefficient 
of variation (%CV) and variance ratios.  Pearson correlation coefficient and multiple 
linear regression were used to investigate the association between uSF in each timed void 
and corresponding 24uSF excretion.  Results: The two-day mean uSF was 50.6 mg 
(SD=29.5) for the 24-h urine, and ranged from 4.5 to 7.5 mg/void for the timed voids.  
The afternoon void uSF had the lowest within-subject variability (49.1%), and lowest 
within- to between-subject variance ratio (0.2). The morning and afternoon void uSF had 
the strongest correlation with 24-h uSF for both mg/void (r=0.80 and r=0.72) and 
mg/creatinine (r=0.72 and r=0.67), respectively. Finally, the afternoon void uSF along 
with other covariates had the strongest predictive ability of 24-h uSF excretion (mg/void) 
(Adjusted R2= 0.69; p=0.002), whereas the morning void had the strongest predictive 
 
ii 
ability of 24-h uSF excretion (mg/g creatinine) (adjusted R2= 0.58; p=0.008). 
Conclusions: The afternoon void uSF had the most favorable reproducibility estimates, 
strong correlation with 24uSF excretion, and explained greatest proportion of the 
variability in 24uSF. USF in mg/void may be better to use than uSF in mg/g creatinine as 
a biomarker in spot urine.  These findings need to be confirmed in a larger study, and in a 
study population with a wide range of sugars intake.   
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CHAPTER 1 
INTRODUCTION 
 
Added sugars consumption has increasingly contributed to total energy intake in 
the U.S., over the last several decades. The most significant increase in calories from 
added sugars was found to be from 1977 to 2003 (Powel et al., 2016). In 2011-2012, 
children and adults in the U.S. consumed 17% and 14% of their total energy from added 
sugars, respectively (Powell et al, 2016). While added sugars are a large component of 
the American diet, the implications of high sugars consumption are not explicitly 
understood. So far, there has been sufficient evidence to conclude that sugars are a 
significant determinant of body weight likely due to providing excess energy (Te 
Morenga et al, 2012), and increase the risk of metabolic disease (Te Morenga et al., 
2014).  Yet, the evidence on sugars in relation to type 2 diabetes (Lean & Te Morenga, 
2016) and cancer risk (Tasevska et al., 2012) is largely inconclusive. Gaining better 
understanding of sugars-disease associations is very important to help make stronger 
recommendations to build healthier communities.  
Associations between sugars and risk of disease are difficult to assess due to 
unreliability of dietary intake, which is an important obstacle in determining true diet-
disease associations (Freedman et al., 2011).  Self-reporting dietary instruments, such as 
food frequency questionnaires (FFQ), 24 hour dietary recalls, and diet records are main 
methods of measuring intake in population studies; however, they are flawed with 
measurement error (Kipnis et al., 2003).  Memory issues, inability to estimate portion 
size and to conceptualize intake over an extended periods of time (Thompson & 
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Subar, 2012), as well as social desirability, varying interpretation of questions, and body 
dissatisfaction can cause people to misreport their food intake (Tooze et al., 2004). 
Additionally, it has been found that energy dense foods are more likely to be 
underreported (Subar et al., 2003). Foods containing added sugars are particularly prone 
to being misreported as they are perceived to be unhealthy (Krebs-Smith et al., 2000; 
Price et al., 1997). The underreporting of sugars intake may seriously affect the ability to 
confirm disease and sugars associations, and more objective measures of diet are needed 
(Tasevska et al., 2011).  
Biomarkers have been identified as one tool to overcome the problem of 
measurement error in self-reported dietary intake (Bingham, 2002), and can help 
strengthen diet-disease associations (Freedman et al., 2010; Freeman, 2014). The sum of 
sucrose and fructose measured in 24-hour urine has been developed as a biomarker of 
total sugar intake in highly controlled feeding studies conducted in the UK (Tasevska et 
al., 2005). The sum of the 30-d mean of sucrose and fructose measured in 24-h urine in 
13 participants consuming their usual diet was found to be highly correlated with 30-d 
mean total sugars (rSUG = 0.84; P < 0.001) and sucrose intake (rSUC = 0.77; P = 0.002).  
Although characteristics and performance of this biomarker are highly promising 
(Tasevska, 2015), collection of 24-h urine samples is not always feasible in large 
population studies. Collection of spot samples can be easily implemented in research 
protocols compared to 24-h samples; however, the utility of the sugars biomarker 
measured in spot urine has never been investigated. Spot urine samples as a matrix for 
biomarker measurement are being increasingly investigated due to ease of collection 
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(Wang et al., 2013) and could have major implications in population research. 
This thesis aims to investigate the use of spot urine for the measurement of 
urinary sucrose and fructose excretion as a proxy to the gold standard 24-h urine 
collection. 
Aim 1: To investigate reproducibility (i.e., describe the within-subject and 
between-subject variability) of sucrose and fructose excretion in spot urine; 
Aim 2: To investigate the correlation of sucrose and fructose from each spot 
urine with the corresponding 24-h sucrose and fructose excretion, and to 
determine which spot urine will be most indicative of 24-h urinary excretion.   
Aim 3: To investigate if age, gender, body mass index (BMI), time of last 
meal, and other characteristics will improve the relationship between sucrose 
and fructose measured in spot and 24-h urine.    
 
 Purpose statement: 
This was the first controlled feeding study to investigate the performance of 
sucrose and fructose in spot urine as a biomarker of sugars intake in the US. Using the 
spot urine measure for assessing sugars that can be easily incorporated in protocols of 
population studies can have a great impact on elucidating the association between sugars 
intake and chronic disease risk. Given the American diet is high in added sugars (Ervin & 
Ogden, 2013), reliably determining these associations is very important to help make 
stronger dietary guidelines and reinforce recommendations for the public. When sugar-
disease associations are better understood, policies can be created to make healthier 
communities.  
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 Participants were committed to a fifteen-day highly controlled feeding study 
where they collected 24-hour urine samples on eight alternating days. On two of these 
eight 24-hour urine collection days, each urine void was collected in a separate container 
during the 24-hour urine collection period as a multiple spot urine collection. Sucrose and 
fructose measured in spot urines were compared to sucrose and fructose in the 
corresponding 24-hour urine collection to determine their relationship. Lastly, other 
variables such as age, gender, BMI, time of last meal, and physical activity that may have 
an effect on the investigated association were measured, and their effect was explored. 
While participants’ dietary intake can be determined from the highly controlled feeding 
study, dietary intake data were not utilized in this investigation. Instead, 24-h urinary 
sucrose and fructose were measured and used as a surrogate measure of intake. 
The recovery of orally administered para-amino benzoic acid (PABA) was 
assessed to determine the completeness of 24-h urine collection (Bingham & Cummings, 
1983). Measuring completeness of urine collections is essential, because incomplete 
collections can affect estimates of the biomarker and characterizing its performance as a 
dietary biomarker.  
 
Definition of terms:  
• 24 hour urine- composite urine collected for 24 hours, starting with the collection 
of the second morning void, and finishing with the first morning void of the 
following day. 
• Spot urine- single urine sample collected by a participant, which can be untimed 
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or timed (i.e., collected at a specific time during the day, e.g., first morning void) 
• Biomarker- a compound measured in any biological sample that can reflect intake 
sufficiently, acting as an objective measure of true intake. 
• Sucrose- a disaccharide by chemical structure composed of one molecule of 
glucose and one molecule of fructose. 
• Fructose- fruit sugar, a monosaccharide by chemical structure. 
• Total sugars- the sum of all free monosaccharides (glucose, fructose and 
galactose) and disaccharides (lactose, sucrose and maltose), naturally-occurring or 
added to foods and beverages, regardless of the food source (Cummings & 
Stephen, 2007; Vos et al., 2016).   
• Added sugars- the sum of any monosaccharide and disaccharide used as 
ingredients in processed and prepared foods, soft and alcohol drinks, jams and 
jellies, candies, and ice cream as well as sugars eaten separately or added to foods 
at the table (Bowman, 2017).  
• Free sugars – a term used by the World Health Organization for added sugars, 
however this term includes sugars naturally present in fruit juices and juice 
concentrates. 
• Measurement error -the difference between measured and true value. 
 
Limitations (problems inherent to the design): 
• The spot urine collection protocol is rather complex as each spot urine void will 
be collected in a separate container during the 24-hour urine collection period, 
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thus mislabeling or incomplete collections could occur. 
• This biomarker is excreted between 2-6 hours postprandially, therefore the timing 
of the last meal consumed before the spot urine is collected is expected to affect 
the excretion of the biomarker. 
• Dietary intake data were not available for this analysis, therefore the association 
between sucrose and fructose in spot urine and intake could not be investigated.  
Instead, sum of 24-h urinary sucrose and fructose excretion was be used as a 
surrogate measure of intake. 
 
Delimitations (narrow the scope of the study):  
• The total sugars intake of our study population may not be generalizable to the US 
population. 
• Inclusion: non-smoking, age 18 and 70 years old, having a BMI of less than 35 
kg/m2, having no known allergy to sunscreen or PABA, be willing to refrain from 
taking dietary supplements over the 10-week study period, and residing in the 
Phoenix Metropolitan Area. 
• Exclusion: presence of diseases that can affect nutrient absorption or metabolism, 
such as autoimmune diseases (e.g., type 1 diabetes, inflammatory bowel disease, 
celiac disease), endocrine (e.g., type 2 diabetes, hyper or hypothyroidism), 
stomach disorders (e.g., ulcers, gastrointestinal bleeding), diseases that affect 
urine excretion (e.g., kidney disease, urinary incontinence), or require any dietary 
restrictions (e.g., celiac disease); participation in any diet related research study or 
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trying to lose weight over the last four months; known allergy to sunscreen; if 
their fasting blood glucose or HbA1c were greater or equal to 100 mg/dl and     
5.7 % respectively, based on the screening blood draw; and for women, being 
pregnant, planning to become pregnant in the next 15 weeks or breastfeeding. 
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CHAPTER 2 
LITERATURE REVIEW 
Definition of sugars  
Sugars, a type of carbohydrate, include three subgroups: monosaccharides, 
disaccharides, and polyols (sugar alcohols). Monosaccharides are the building blocks of 
di-, oligo- and polysaccharides (Cummings & Stephen, 2007). Monosaccharides are 
sweet tasting/water-soluble molecules, which include glucose, galactose, and fructose. 
Disaccharides include sucrose, composed of one molecule of glucose and one molecule 
of fructose; lactose, composed of glucose and galactose; and maltose, composed of two 
molecules of glucose. Fructose is naturally found in honey, fruits, vegetables, and other 
plants; however, it is also frequently derived from corn to produce high fructose corn 
syrup (Cummings & Stephen, 2007), which is commonly used as added sugar in 
processed foods and sugar sweetened beverages.  Lactose is naturally found in dairy 
products.  Sucrose is naturally found in sugar cane and sugar beets, which are used to 
produce table sugar, a common added sugar in the American diet, but is also a naturally 
occurring sugar in fruits and vegetables. Polyols are sugar alcohols, including sorbitol 
and xylitol, and are often used as a sugar replacement (Cummings & Stephen, 2007; IFIC 
Foundation, 2016). Though, they are found naturally in some fruits, they can also be 
manufactured (Cummings & Stephen, 2007). Their structure differs slightly from 
monosaccharides and therefore the digestion, absorption, and metabolism is dissimilar. 
Additionally, polyols taste sweet but they are not calorically equal to monosaccharides 
(IFIC Foundation, 2016).  
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The United States Federal Drug Administration (FDA) defines sugars or total 
sugars as “the sum of all free mono and disaccharides” which include glucose, fructose, 
galactose, lactose, sucrose, and maltose, naturally occurring or added to foods and 
beverages, regardless of the food source (Cummings & Stephen, 2007; Vos et al., 2016).  
Added sugars (Bowman, 2017) are the sum of any monosaccharide and 
disaccharide used as ingredients in processed and prepared foods, soft and alcohol drinks, 
jams and jellies, candies, and ice cream as well as sugars eaten separately or added to 
foods at the table. The World Health Organization uses the term ‘free sugars’ for added 
sugars, however this term also includes sugars naturally present in fruit juices and juice 
concentrates. Added sugars are commonly added to sweeten a food product, improve 
palatability, or as fillers in processed food, such as in low fat items (Cummings & 
Stephen, 2007; Erickson & Slavin, 2015; Wittekind & Walton, 2014). Because of this, 
some fat free dairy or grain products have higher amounts of added sugars. Although 
added sugars are frequently consumed (Powell et al., 2016), the implications of excess 
consumption are not well understood.  
Naturally occurring sugars, implied by their name, are naturally occurring in 
foods. They are sometimes regarded as ‘healthier’ than added sugars; however, this is 
controversial because the chemical structure of added and naturally occurring sugars is 
identical (World Health Organization, 2015).  Nonetheless, added sugars may have more 
adverse metabolic effects as they are more rapidly available for absorption and 
metabolism due to disrupted food matrix of processed foods, whereas naturally-occurring 
sugars are incorporated into the food’s cellular structure and therefore slower to enter 
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metabolism (Johnson et al., 1996).  
 
Sugars absorption and metabolism  
 Carbohydrates are chemically and mechanically digested in the gastrointestinal 
tract until they are hydrolyzed into monosaccharides (Brody, 1994).  Simple 
carbohydrates (disaccharides) are digested quicker and therefore can be absorbed in the 
duodenum, whereas complex carbohydrates (polysaccharides) take longer to fully break 
down and may be absorbed in the jejunum and ileum. Final digestion occurs by brush 
boarder enzymes, maltase, lactase, and sucrase; sucrase hydrolyses sucrose into glucose 
and fructose, lactase hydrolyses lactose into glucose and galactose, and maltase 
hydrolyzes maltose into two glucose molecules. 
 Absorptive epithelial cells, enterocytes, are lined with transporters to assist 
absorption of glucose, galactose, and fructose across the phospholipid membranes. 
Glucose and galactose are absorbed across the apical membrane via co-transport with 
sodium (GLUT1) (Brody, 1994). In the absence of sodium, the driving force for glucose 
absorption is lacking. Fructose is absorbed across the apical member via the GLUT5 
transporter. These molecules then cross the basolateral membrane by facilitated (GLUT2) 
or simple diffusion via the concentration gradient into the capillaries and enter the blood 
stream. Glucose, fructose and galactose are transported to the liver by the hepatic portal 
vein, where fructose and galactose are rapidly converted into glucose (Mann & Truswell, 
2007). 
 Absorbed glucose directly affects blood glucose levels and is controlled by uptake 
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in different tissues. Cells in these tissues absorb glucose via GLUT 1. Some tissues, 
skeletal muscle, heart muscle, and adipocytes use insulin dependent transporter GLUT 4 
for the uptake of glucose. Regardless of the type of transporter, these cells immediately 
convert glucose molecule into glucose-6-phosphate (G6P). The brain specifically uses 
GLUT 1 and GLUT 3. This phosphorylation traps the glucose inside the cell. Cells 
perform glycolysis, the breakdown of glucose to produce energy. When the cells reach 
saturation of glucose, they convert the excess glucose into glycogen or fatty acids (Brody, 
1994). Gluconeogenesis is performed when not enough glucose is present in the blood, 
providing an energy source to sustain cells and tissues (Mann & Truswell, 2007). 
 Fructose on the other hand does not directly impact blood glucose levels as it 
must reach hepatic cells to be metabolized. It is absorbed by GLUT 5 and then it is 
phosphorylated by fructokinase into fructose-1-phosphate (F1P). Further metabolism 
results in intermediates for the glycogenesis pathway and triglyceride synthesis. 
Sugars provide 4 kcal/g similar to all digestible carbohydrates. As glucose, fructose, and 
galactose are metabolized, energy is stored. Energy dense foods, such as foods high in 
added sugars, are characterized as having high caloric value, versus nutrient dense foods, 
which have high nutrient value. Energy dense diets may promote excess adiposity from 
the storage of excess energy, leading to weight gain (World Health Organization, 2015). 
There is a debate as to whether fructose and glucose have similar affects. They are 
calorically equivalent but have prominently different metabolic fate, as glucose directly 
impacts blood glucose levels and fructose does not (Vos et al., 2016). 
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Sugars guidelines 
Well-defined nutritional guidelines regarding sugars consumption have long been 
lacking.  In 2002, the Institute of Medicine (IOM) proposed a recommendation that less 
than 25% of total energy intake should be from added sugars (IOM, Food and Nutrition 
Board 2002). In 2009, the American Heart Association (AHA) recommended reducing 
added sugars consumption to ‘no more than half of the discretionary calories allowance’, 
which for most women is ≤100 kcal/d (6 teaspoons) and for most men is ≤150 kcal (9 
teaspoons) per day from added sugars (Johnson et al., 2009).  
Most recently, the World Health Organization (WHO) released recommendations 
stating that adults and children should consume less than 10% of their energy intake from 
free sugars. Additionally, the WHO advises cutting free sugars to less than 5% of total 
energy, which is equivalent to six teaspoons or 25 grams per day for an adult with a 
healthy BMI, to further reduce the risk of chronic diseases (World Health Organization, 
2015). Decreasing added sugar intake to recommended levels will reduce energy content 
of the diet without compromising nutrient adequacy (Vos et al., 2016; World Health 
Organization, 2015). The most recent 2015-2020 Dietary Guidelines for Americans, 
published by the USDA, recommend limiting added sugars consumption to less than 10% 
of allotted calories per day (US Department of Health & Human Services and USDA, 
2016). 
 
Added sugars intake in the U.S.  
Sugars intake in the U.S. remains above the recommend levels (US Department of 
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Health & Human Services and USDA, 2016; Powell et al., 2016).  A study by Powell et 
al. (2016) examined added sugars intake in US children and adults between 1977 and 
2012, using nationally representative data. They found that in 2003-2004, children 
consumed 18% and adults 15% of their total energy intake from added sugars, a rise from 
14% and 12% in 1977-1978, respectively. Although in 2011-2012, added sugars intake 
somewhat decreased to 17% in adults and 14% in children, it still remains above the 
recommended 10% of the total energy intake.  
Park et al. (2016) investigated socio-demographic and behavioral factors that 
contribute to added sugars consumption among US adults using data from the 2010 
National Health Interview Survey data (n=24,967).  The median sugars intake in this 
population was 17.6 tsp/day (296 kcal) for men and 11.7 tsp/day (197 kcal) for women. 
Based on findings from the National Health and Nutrition Examination Survey 
(NHANES) 2005-2010, on average men consumed 335 kcals from added sugars, whereas 
women consumed 239 kcals (Ervin & Ogden, 2013).  
Park et al. (2016) also discussed factors associated with sugars intake greater than 
22 tsp /day for men (equivalent to 92.4 g or 18.5% EI on a 2000 kcal diet) and 14.6 tsp 
/day for women (equivalent to 61.3 g or 12.2% EI on a 2000 kcal diet). They identified 
that being a smoker, less educated, and less physically active, having low income, and 
infrequently consuming alcohol were associated with increased added sugars 
consumption. Based on NHANES 2005-2010 data, Ervin & Ogden (2013) reported that 
added sugars contributed to a larger percentage of their total energy intake for Non-
Hispanic black men (14.5%) compared to non-Hispanic white (12.8%) and Mexican-
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American men (12.9%). Similar trends were observed in women with 15.2%, 13.2%, and 
12.6% of total energy from added sugars consumed by non-Hispanic black, non-Hispanic 
white and Mexican-American women, respectively. The differences in percentage of 
calories was not significant between non-Hispanic white and Mexican-American men and 
women; however, these results were noted in adult populations only. 
Ervin & Ogden (2013) further reported that more calories from added sugars 
came from foods (67%) than from beverages (33%).  Additionally, these calories were 
found to be largely consumed at home, suggesting that food items high in added sugars 
are typically found in the home. Total calories from added sugars were found to have an 
inverse relationship with age and income. Added sugars consumption across ages 20-39, 
40-59, and ≥ 60 years was 397, 338, and 224 kcals in men, and 275, 236, and 182 kcals in 
women, respectively.  In summary, while added sugars intake is elevated in the U.S. 
population, the intake varies based on gender, age, ethnicity, income level, education 
level, and smoking status. 
 
Sugars and disease risk  
The association between sugars intake and dental caries has long been established 
(Freeman, R., 2014; Vos et al., 2016), while the association with other disease outcomes 
has been less understood (Key et al., 2002).  More recently, the WHO commissioned a 
systematic review that included 30 randomized controlled trials (RCTs) and 38 cohort 
studies to investigate the association between dietary sugars and body weight (Te 
Morenga et al., 2012).  The analysis of the RCTs showed that limiting sugar-containing 
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foods in individuals following an ad libitum diet led to significant reduction in body 
weight (-0.80 kg, 95% CI = 0.39-1.21; p<0.001) (Te Morenga et al., 2012).  Analysis of 
the cohort studies revealed that those with highest sugar sweetened beverage (SSB) 
intake were 55% more likely to become obese (HR = 1.55, 95% CI = 1.32 – 1.82) 
compared to those with the lowest intake.    
Diet is believed to be the second influential factor on disease development, 
specifically cancer (Key et al., 2002).  However, although sugars consumption is a highly 
prevalent dietary behavior, its association with cancer remains largely unknown.  
Potential mechanisms for this association include increased insulin and insulin-growth 
growth factor-I (IGF-I) synthesis that may promote caricinogenesis (Kaaks & Lukanova, 
2001), induce oxidative stress (Ceriello et al., 1999) and weight gain (Renehan et al., 
2015; Te Morenga et al., 2012).  In their prospective investigation of sugars in relation to 
24 cancer sites, in approximately half a million participants of the NIH-AARP cohort, 
Tasevska et al. (2012) reported an increased risk of esophageal adenocarcinoma and 
small intestinal cancer with high intake of added sugars (HRQ5 vs. Q1: 1.62, 95% CI: 1.07–
2.45; Ptrend = 0.01) and added fructose (HRQ5 vs. Q1: 2.20, 95% CI: 1.16–4.16; Ptrend = 
0.009), respectively, but found no association with any of the highly prevalent types of 
cancer, such as breast or colorectal cancer.  In an analysis of the same cohort, the authors 
found total sugars and fructose but not added sugars intake associated with an increased 
risk of total mortality (total sugars, HRQ5 vs. Q1: 1.13, 95% CI: 1.06 - 1.20; Ptrend =0.0001); 
fructose, HRQ5 vs. Q1: 1.10, 95% CI: 1.04 - 1.17, Ptrend =0.0001, respectively).  
Nonetheless, in a recent prospective analysis of NHANES III (1988–2006), Yang et al. 
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(2014) found that US adults consuming 17–21% and >21% of energy from added sugars 
had significantly increased risk for cardiovascular disease (CVD) mortality compared to 
those consuming ≤8% of energy from added sugars (HR: 1.38, 95% CI: 1.11-1.70; and 
2.03, 95% CI: 1.26-3.27, respectively).  This association was consistent across age, sex, 
race, ethnicity, education, physical activity level, health eating index (HEI) score, and 
BMI.  They also reported that total caloric intake from added sugar rose from 15.7% to 
16.8% and then decreased to 14.9% over the respective years of NHANES data collection 
(1988-1994; 1999-2004; 2005-2010). During 2005-2010, 71.4% of adults consumed 
more than the recommended calorie intake (10%) from added sugar and 10% of adults 
consumed more than 25% of their daily calories from added sugar.  The range of added 
sugars intake in this NHANES analysis was rather wide, i.e., the 10th and 90th percentile 
were at 7.5 and 25% of energy intake (Yang et al., 2014), while in the NIH-AARP study, 
which included mainly educated 50- to 69-y-old adults, at 4 and 18% of energy intake, 
respectively (Tasevska et al., 2012). Lower intake of added sugars in the later cohort may 
have prevented an observation of higher risks with respect to added sugars and CVD 
mortality risk. 
The American Heart Association reviewed and graded scientific evidence on 
added sugars intake in relation to CVD risk and CVD related outcomes, such as elevated 
blood pressure, uric acid levels, dyslipidemia, insulin resistance, diabetes mellitus, 
nonalcoholic fatty liver disease, and obesity among children (Vos et al., 2016). They 
found that added sugars intake far below the current consumption levels significantly 
increased risk for CVD disease, which association was mediated by increased energy 
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intake, adiposity and dyslipidemia.  Their findings supported the recommendation that 
children age ≥ 2 years should limit their added sugars intake to ≤ 25 g/day (100 kcal or 6 
tsp), while children < 2 years should avoid added sugars.  This means that at levels of 
common consumption, the risk for these outcomes is likely higher, increasing awareness 
to the high risk even at low levels of consumption.  
Te Morenga et al. (2014) conducted a systematic review and meta-analysis of 
RCTs that examine effects of dietary free sugars on blood pressure and lipids (minimum 
trial duration was 2 weeks). Out of 39 trials included, 37 trials reported lipid outcomes 
and 12 trials reported blood pressure outcomes. They observed that higher sugars 
consumption was associated with an increase in triglycerides, cholesterol, low density 
lipoprotein (LDL) and high density lipoprotein (HDL), independent of body weight. The 
reported mean difference in these cardiometabolic risk outcomes between participants on 
high and low free sugars diet was 0.11 mmol/L (95% CI = 0.07- 0.15) for triglycerides, 
0.16 mmol/L (95% CI = 0.10-0.24) for cholesterol, 0.12 mmol/L (95% CI = 0.05-0.19) 
for LDL, and 0.02 mmol/L (95% CI = 0.00-0.03) for HDL, all of which were statistically 
significant. The strongest association between sugars intake and blood pressure was 
found in eight week long trials with a 6.9 mm Hg increase in systolic blood pressure 
(95% CI = 3.4-10.3) and 5.6 mm Hg increase in diastolic blood pressure (95% CI = 2.5-
8.8) for a higher sugars intake diet (Te Morenga et al., 2014). Based on evidence from 
systematic reviews and individual studies that investigated dietary sugars, specifically 
SSBs, and type 2 diabetes mellitus (T2DM) incidence, Lean & Te Morenga (2016) 
concluded that the evidence directly linking sugars to T2DM is still unconvincing. While 
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there was a consistent association between SSBs and T2DM, the association was 
weakened when data were adjusted for BMI. Excess caloric intake contributes to weight 
gain, regardless of the origin of the calorie, which promotes T2DM, suggesting that sugar 
reduction as the only intervention will not likely impact diabetes incidence. The evidence 
on sugars intake and glycemia showed that high sugar diets can still maintain good 
glucose control. Yet, more research is needed to fully understand the role of sugars in 
etiology of T2DM and the effect of isocaloric exchange between sugar and non-sugar 
carbohydrates. Whereas the evidence that high sugars intake increases the risk of 
macrovascular complications of T2DM is more established, some studies point out that 
SSBs may promote kidney disease among individuals with T2DM, but not necessarily 
from sugars but from other components of SSBs, such as caramel coloring or phosphoric 
acid (Lean & Te Morenga, 2016). They concluded that the true hazard lies in weight gain 
and obesity, as foods beyond just sugar can contribute to these rising rates. 
Little research has been done to establish a threshold for the potential adverse 
effects of sugars on health. The National Institutes of Health (NIH) and WHO, among 
other organizations, are leading the frontier in investigating effects of added sugars intake 
on health. The consumption of processed foods increases the intake of sugars and with 
food sources of sugars being diverse, it is difficult to assess their intake (Jenab et al., 
2009).  The level of dietary misreporting, which is greater among overweight and obese 
(Lara et al., 2004) who are commonly at higher risk of disease, further complicates the 
investigation of the etiology role of sugars and invalidates the evidence on sugars and 
disease risk. 
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Dietary assessment and issues with self-reported diet 
 
Self-reported food consumption by the individual is the primary way the 
nutritional science community approaches measuring people’s dietary intake. Yet, 
random and systematic errors plague self-reporting. Daily variation of intake, inability to 
estimate portion size, and misreporting the amount and type of food all contribute to 
these errors (Bingham, 2002).  The most commonly used self-reporting dietary 
instruments in population studies include food diary or food record, food frequency 
questionnaire (FFQ), and 24-hour dietary recall (24HRs). Unfortunately measuring 
dietary intake is challenging, while researchers continue to rely on these methods. 
FFQ, a major technique for assessing dietary intake in epidemiologic studies, 
measures usual or long-term intake over weeks, months, or a year (Willett, 2012). It uses 
a food list and a selection of frequency each food item was consumed. Questions on 
quantity can also be included. This tool captures the usual exposure to nutrients or foods 
of interest, rather than intake over a few days. Benefits of FFQ include that it is self-
administered, low cost, and it assesses long-term diet (Willet, 2012). Yet, it has inherent 
flaws, including errors due to misestimated intake averaged over extended periods of 
time, or unwarranted correlations between frequencies and weights of the foods. Validity 
of FFQs can be determined against multiple food records and recalls, or dietary 
biomarkers in a representative sample of the population (Willet, 2012). 
A 24-hour dietary recall is a dietary assessment instrument that measures short-
term intake.  It asks individuals to recall foods and beverages they consumed in the 
twenty-four hours prior to the interview.  A food record is a dietary assessment 
   
20 
instrument where participants are asked to record all foods and beverage consumed over 
a certain period of time, ranging from a few days to a week. Food records and 24-hour 
recalls are open ended, and assess diet consumed on specific days. Food records are 
prospective, whereas 24-h recalls are retrospective methods. These can be repeated 
multiple times to collect enough data to approximate usual intake.  Day to day variability 
in intake contributes to random measurement error (ME) particularly when using 24-h 
recalls to measure intake (Willet, 2012). Foods that are infrequently consumed can be 
missed by 24-recalls, yet combining dietary recalls with FFQ can be beneficial in 
eliminating the issue (Willet, 2012). 
All self-reporting instruments rely on the information given by the subject, hence 
the potential for ME in self-reported diet is high (Bingham et al., 2007). These methods, 
particularly the FFQs, rely on the participant’s memory, which can contribute to ME.  
Also, estimates of food intake may not be objective as people rely on perception and 
conception of portions sizes and averaging intake over time to determine the amount 
consumed (Willet, 2012).  Lastly, people seek social acceptance, thus estimates of intake 
can be biased or skewed because of social desirability issues, especially in face-to-face 
interviews. Underreporting dietary intake is very high when self-reporting methods are 
used (Subar et al., 2003), which results in underestimation of energy and nutrient intakes 
(Newens & Walton, 2016). 
Prentice et al. (2011) used the Nutrition and Physical Activity Assessment study 
(NPASS), a calibration sub-study nested in the Women’s Health Initiative (WHI), to 
evaluate the validity of FFQ, 4-day food record and 24-h recall against dietary 
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biomarkers for energy and protein intake. Each self-reported method considerably under 
estimated energy intake by 20-27% and to a lesser extent protein by 4-10%. They 
discovered that FFQ provided the poorest estimate of energy and protein intake, with 24-
h recall next, while that 4-day food record was found to be most accurate among the three 
instruments.  In the calibrated equations from the regression of the biomarker on each of 
the self-reporting instruments along with BMI, age and ethnicity, the percentage 
biomarker explained was 71.1%, 76.2%, and 71.8% for energy intake, and 39.7%, 63.8%, 
and 55.6%, for protein intake, for the FFQ, 4-day food record, and 24-h recall, 
respectively. This suggests that calibrated equations for these instruments may provide 
useful estimates of energy and protein intake in epidemiological studies. 
The Observing Protein and Energy Nutrition (OPEN) study was another 
validation study that evaluated the extent of dietary misreporting in FFQ and 24-h recalls 
by use of dietary biomarkers (Subar et al., 2003). The study population (n=484) was 
recruited from a suburban area in Maryland. They found that men and women 
underreported their energy intake by 12-14% and 16-20% when using 24-h recalls, and 
by 31-36% and 34-38% when using FFQs, respectively.  The corresponding percentages 
for under-reporting protein intake in men and women were 11-12% and 11-15% for 24-h 
recall, and 30-34% and 27-32% for FFQ, respectively. This ME needs to be accounted 
for in diet disease association studies, and many researchers agree that dietary biomarkers 
may be effective in identifying and quantifying the error.  The correlation between FFQ 
and true intake of protein and energy for women, measured by biomarkers were 0.30 and 
0.10 in women, and 0.32 and 0.20 in men, respectively (Kipnis et al., 2003). When 24-h 
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recall was used as a reference instrument to assess validity of the FFQ, these correlations 
were largely overestimated (women: 0.33 and 0.26 for protein and energy; men: 0.31 and 
0.44 for protein and energy). Hence, using FFQ to assess diet in epidemiologic studies 
may weaken the observed effect of diet on disease risk (Kipnis et al., 2003). Furthermore, 
the use of 24-h recall as a reference instrument can seriously overestimate the validity of 
FFQ, and invalidate interpretation of findings.  The lack of reliable dietary intake data has 
made establishing diet-disease associations very challenging.  
Freedman et al. (2010) explains how biomarkers can be used in addition to self-
reporting measures to strengthen diet disease associations. While one method by itself 
may not be sufficient, together dietary biomarkers and self-reports may be able to detect 
important diet-disease relationships. 
 
Dietary biomarkers  
Dietary biomarkers are defined as compounds measured in any biological sample 
that can reflect intake sufficiently, acting as an objective measure of true intake 
(Bingham, 2002). So far, four classes of dietary biomarkers have been identified: 
recovery, concentration, replacement, and predictive. 
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Figure 1:  Classifications of dietary biomarkers (Jenab et al., 2009) 
Recovery biomarkers are based on the metabolic balance between intake and 
excretion over a fixed period of time, and can provide an estimate of absolute intake 
(Kaaks et al., 1997).  For example, doubly labeled water, which measures total energy 
expenditure (Schoeller, 1999), and urinary potassium and nitrogen which measure 
potassium (Tasevska et al., 2006) and protein intake (Bingham & Cummings, 1985), 
respectively.  
Concentration biomarkers correlate with intakes levels of the food or nutrients 
but total levels cannot be determined (Kaaks et al., 1997). These include carotenoids, 
vitamin C, fatty acids, etc. in plasma or serum (Figure 1). Replacement biomarkers are 
type of biomarkers that replace estimates of nutrients for which databases are inadequate 
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or unavailable. Predictive biomarkers are type of biomarkers that can predict intake 
after being adjusted for certain level of error in the biomarker, with the assumption that 
the error is stable across populations (Tasevska et al., 2011).  The predictive biomarker 
category is relatively new, and 24-h urinary biomarker to measure sucrose and fructose is 
the only member of this category so far. Only small fractions of the total sugars 
consumed are recovered in urine and because of this, this category is different compared 
to recovery biomarkers (Willet, 2012). 
Use of dietary biomarkers do not come without challenges, however.  Individual 
factors, metabolic and genetic, can affect the association between biomarker and dietary 
intake (Jenab et al., 2009). Additional aspects that affect biomarkers include sensitivity to 
intake, specificity and non-dietary determinants, as well as biological sample collection, 
processing, analysis and storage (Willet, 2012).   
The usefulness of different biomarkers varies depending on the nutrient being 
measured (Willet, 2012). In order for a biomarker to be valuable, it must measure what it 
is supposed to measure, suggesting sensitivity to intake is a substantial factor. 
Homeostasis, bioavailability, and time integration all play a role in the biomarkers 
sensitivity to intake. Due to homeostatic mechanisms, concentrations of some 
nutrients/compounds can be well controlled in the body, making the use of these 
measurements as biomarkers of intake difficult. This in particular refers to the class of 
concentration biomarkers. Because of the homeostatic mechanisms, the relationship 
between dietary components and the biomarker is usually not linear. For many nutrients, 
the association may be linear across a certain range and then plateaus. If the plateau phase 
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is large and it is within the normal range of intake (i.e., serum retinol), then the biomarker 
will not be informative of intake, making the measurement impractical (Willet, 2012). If 
the association is linear across the normal range of intake for the nutrient, then biomarker 
measurements can distinguish between low, average and high intakes, making the 
measurement useful.  Another component to consider is bioavailability, or intestinal 
absorption, transport, and metabolism. Bioavailability can increase variation of the 
measured biomarker. Both chemical structure and the food matrix can influence 
bioavailability.  The information on time integration of the biomarkers is essential, as it 
determines the application of the biomarker. Biomarker measuring a nutrient stored in 
adipose tissue will reflect long-term dietary intake, versus biomarkers in urine or plasma, 
which typically reflect recent dietary changes. Short-term fluctuations in intake may be 
seen as large within-person variation of the biomarker. If within-person variation is large, 
it is difficult to predict a long-term intake based on a single measure. Repeated sampling 
and analysis may alleviate the problem of high within-person variability in the biomarker, 
and provide long-term estimate of intake. 
Specificity is another component that can affect biomarkers of interest. Some 
biomarkers have low specificity, as some nutrient concentrations will correlate with other 
nutrient levels, making it difficult to measure a specific compound (Willet, 2012). This is 
because dietary nutrients have shared food sources. Additionally, some biomarkers are 
the result of the metabolism of other dietary components, making confounding variables 
difficult to identify (Willet, 2012). Non-dietary determinants also play a role, such as 
genetics, environment, and lifestyle. These factors must be considered when classifying 
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subjects according to their biomarker level.  
Lastly, methodological aspects can affect dietary biomarkers. These include 
laboratory measurements, methods to process, preserve and store samples (i.e., 
contamination and stability) (Willet, 2012). Timing of sampling and proper storage 
techniques is essential to ensure the validity of the biomarker measurements. The goal is 
to maintain the concentration through the collection, processing, and storage steps.  
 
Dietary biomarker for total sugars intake 
 
The newly developed biomarker of total sugars intake, sucrose and fructose in 24-
h urine (24uSF) belongs to the class of predictive biomarkers.  It is based on the fact that 
in healthy individuals, very small measureable amounts of sucrose and fructose are 
excreted in urine, which were found to be highly predictive of total sugars intake 
(Tasevska et al., 2005). Sucrose occurs in urine probably because it escapes enzymatic 
hydrolysis in the duodenum (Kawabata et al., 1998; Luceri et al., 1996; Tasevska, 2015). 
Intact sucrose, hence, passes through the intestinal wall, and once in the blood stream, is 
filtered into urine by the kidneys. However, gastrointestinal damage can also increase 
permeability and promote leakage of intact sucrose through damaged gastrointestinal wall 
(Kawabata et al., 1998). Fructose occurrence in the urine is probably due to fructose 
escaping hepatic metabolism and being excreted in the urine (Tasevska, 2015). Nakamura 
& Tamura (1972) observed 9.54 mg of fructose in urine 4 hours after taking 10 g of 
sucrose mixture. Although some amount of glucose can be measured in urine, glucose 
excretion appears to be person-specific and is not reflective of dietary intake due to 
insulin-controlled glucose reabsorption occurring in the kidneys (Tasevska, 2015). 
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Luceri et al. (1996) first discovered urinary excretion of sucrose and fructose as a 
marker of sucrose intake. In this study, nine participants consumed their habitual diet for 
one week, followed by a low sucrose diet for three days, while keeping a daily diet log 
over the entire study 10-d study period.  On the last day of their one week habitual diet 
period and the 3-d low sucrose diet period, they provided a fasting urine sample, and 
another 3 voids collected within 2 hours of breakfast, lunch and dinner (i.e., at 8:00 am, 
10:00 am, 3:00 pm, and 10:00 pm). This study expressed urinary sugars concentrations 
per gram urinary creatinine. They observed a reduction in urinary excretion of sucrose 
(p<0.05), glucose (p<0.001), and fructose (p<0.001) when participants followed the low 
sucrose diets.  Yet, when they averaged the urinary excretion levels measured in each of 
the four timed urines for the habitual and low sucrose diet, and related those with sucrose 
intake of the collection day, they found sucrose intake highly significantly correlated with 
sucrose (r=0.7; p<0.01) and fructose (r=0.82; p<0.01), but not glucose excretion (r=0.35; 
p>0.05).  This suggested that urinary sucrose and fructose may be reflective of sucrose 
intake (Luceri et al., 1996) 
As a tool to more accurately measure sugars intake, urinary sucrose and fructose 
were then investigated under highly controlled conditions in a feeding study design in 
participants collecting 24-h urine collections (Tasevska et al., 2005). Two studies were 
conducted in a volunteer suite to investigate whether sucrose and fructose in 24-h urine 
can be used as biomarkers of total sugars intake. The first study (n=12) investigated 
whether the amount of sucrose and fructose detectable in urine is dose dependent to total 
sugars intake. Participants received a low sugars diet (63 ± 5 g/day), medium sugars diet 
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(143 ± 5 g/day), or a high sugars diet (264 ±  3 g/day) for 10 days each. The percentage of 
total sugars from sucrose were reported at 34.4%, 37.4%, and 48.9% respectively. Out of 
the 10 days, participants provided 24-hour urine samples on day 4 to 7. The mean sucrose 
and fructose excretion increased in a dose-response manner across low, medium and high 
sugars intake periods (Tasevska et al., 2005). Although, the within-subject variation for 
urinary sugars excretion was high while subjects were on the same level of sugars, the 
mean urinary excretion of both sucrose and fructose were statistically significantly 
different between the periods of different sugars intake (urinary sucrose: Wilks' Lambda 
= 0.082, F2,9 = 50.1, P < 0.001, Partial eta squared = 0.918; and fructose: Wilks' Lambda 
= 0.077, F2,9 = 54.3, P < 0.001, Partial eta squared = 0.923) (Tasevska et al., 2005). 
The second feeding study (n=13) investigated the performance of the biomarker 
with participants consuming their normal diet varying in sugars intake day to day, while 
maintaining their occupational and recreational activities. For 30 days, participants 
consumed their habitual diet in a controlled environment in a residential volunteer suite 
(Tasevska et al., 2005).  Consumed food was carefully measured and the UK food 
composition tables were used to determine dietary intake (McCance & Widdowson, 
2002).  Participants collected 24-h urine daily over the 30-d study period, which were 
analyzed for sucrose and fructose. Participants total sugars intake ranged from 95 to 323 
g/day, averaging around 202 g/day or 29.2% of total energy intake. The sum of the 30-d 
mean of urinary sucrose and fructose was highly correlated with 30-d mean total sugars 
(r = 0.84; P < 0.001) and sucrose intake (r = 0.77; P = 0.002).   
From these two feeding studies, 24uSF was identified as a biomarker for total 
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sugars intake in free-living individuals. Because this study found the recovery of sugars 
to be low, i.e., 0.02-0.05% of total sugars intake, the 24uSF biomarker was not classified 
as a recovery biomarker, but a new category of predictive biomarkers was proposed. 
24uSF is not considered a concentration biomarker because it is related to intake in a 
dose-dependent and time sensitive manner (Tasevska et al., 2005).  
Following these findings, Tasevska et al. (2011) used the OPEN study (n=484) to 
investigate the validity of the National Cancer Institute Diet History Questionnaire 
(DHQ) and 24-h recall to assess total sugars intake. From 1999 to 2000, 261 men and 223 
women completed an FFQ (DHQ), and 24-h recall two times within 14 days, and 
provided two 24-h urine collections. The sum of fructose and sucrose amount measured 
in 24-h urines was used as a predictive biomarker for total sugars intake, which was then 
used to estimate the ME of the FFQ and 24-h recall.  The correlation between true and 
self-reported total sugars density was 0.5 for the FFQ and 0.6 for the average of two 24-h 
recall in men, and 0.2 and 0.3 in women, respectively, supporting the need for using this 
biomarkers in diet-disease association studies (Tasevska et al., 2011). 
 
Collection of 24-h urine samples for biomarker measurement 
 
 Urinary excretion of various compounds can provide valuable information on 
recent dietary intake. Typically, these compounds are measured in 24-h urine. 24-h urine 
samples are all urine voids collected over a 24-hour period, and although they can be 
cumbersome, they are feasible in motivated participants. Although 24-h biomarker 
measurements are useful in establishing total dietary intake of a nutrient, there is a high 
likelihood for incomplete 24-h collections.  To measure the completeness of a 24-h 
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urine sample or compliance by a subject, para-aminobenzoic acid (PABA) can be used 
(Bingham & Cummings, 1983). PABA is absorbed and completely excreted with little 
variation between individuals within 6 hours of oral administration.  When three doses of 
PABA are taken spread out on the urine collection day (240 mg total), recovery of ≥85% 
of PABA in urine indicates a complete urine collection (Bingham & Cummings, 1983).  
This method is often used in 24-h urine studies to identify complete versus incomplete 
urine collections. 
 
 
Collection of spot urine samples for biomarker measurement 
 
Due to large participant burden, complex logistics and high cost, collection of 24-
h samples for measurement of biomarkers is not always feasible in large population 
studies, whereas collection of spot urines is more easily implemented. Therefore, 
investigation of the performance and utility of biomarkers measured in spot urine would 
have major implications in population based research. Spot urine is a single urine sample 
collected by a participant, which can be untimed or timed (i.e., collected at a specific time 
during the day, e.g., first morning void). If certain spot urine reflects 24-hour urine 
composition, then those spot urines can be used for biomarker measurement instead of 
using the 24-hour collection sample. The collection of spot urines is much more feasible 
to obtain, and is less prone to collection errors, as seen in 24-hour urine collections 
(Wang et al., 2013; Willet, 2012).   
While spot urine measurement in theory is ideal, an important challenge to 
address for this measurement is diurnal variation in excretion of the biomarker. 
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Diurnal effects can influence biomarker measurements and its use (Willet, 2012). A study 
by Wang et al. (2013) explored the diurnal variation of sodium, potassium, chloride, and 
iodine. The study included 481 free living participants 18-39 years of age collecting one 
24-h urine where each void was collected in a separate container. They investigated the 
use of spot urines for measurement of sodium, chloride, potassium, creatinine, and iodine 
intake against the biomarker measured in the same day 24-h urine collection. Authors 
report diurnal patterns for sodium, potassium, and chloride.  They found that overnight 
urine samples had the lowest concentrations of these nutrients compared to urine samples 
collected during the day. Furthermore, they report consistent excretion of iodine and 
creatinine across different voids. While diurnal variation has been identified in the 
excretion of these nutrients, it has yet to be investigated for the sugars biomarker.  
As the biomarker concentration in a spot collection depends on spot urine volume, 
in order to appropriately study diurnal variation of the biomarker, it is important that its 
concentration is adjusted for the water content of the urine void.   To adjust for volume 
differences in spot urine collections, creatinine is most commonly used. Creatinine is 
excreted in the urine at a relatively constant rate throughout the day, hence it can be used 
to normalize biomarker concentration in a void, i.e., express the concentration per gram 
creatinine (Barr et al., 2005).  Creatinine is excreted in the urine as a product of muscle 
metabolism, and it is highly dependent on muscle mass, but has been also shown to be 
associated with BMI, age, gender and ethnicity (Barr et al., 2005). Furthermore, meat 
consumption (Cross et al., 2011) can cause between-person variation in creatinine 
excretion, therefore the use of creatinine to adjust for urine dilution has some limitations.  
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In the investigation of the performance of the biomarker measured in spot urine, 
the concern is whether the spot urine measurement will sufficiently reflect true dietary 
intake compared to the biomarker measure in 24-h urine collections. In order for a 
biomarker measure in spot urine to be considered a good tool for measurement of dietary 
intake, the spot urine measurement should have a high correlation to 24-h urine 
measurement of the biomarker, for established 24-h urine biomarkers. This will be 
investigated for the sugars biomarker. The following studies found spot urine estimates to 
be indicative of 24-hour urine estimates of the biomarker, and therefore indicate that spot 
urine is an appropriate tool.  
A study by Perrine et al. (2014) measured urinary iodine excretion (UIE) and 
urine iodine concentration (UIC) to estimate population iodine intake levels. They then 
compared UIE and UIC in 24-h and spot urine samples to determine if the spot urine 
sample is a sufficient tool to assess iodine intake. Participants (n=400) collected morning, 
afternoon, evening, and overnight voids and these samples were analyzed for iodine. 
They measured urinary iodine excretion (UIE) and urine iodine concentration (UIC) in 
the urine samples. Median 24-h UIE was reported as 173.6 µg/day and median 24-h UIC 
was reported as 144.8 µg/L. From the timed spot collections, 24-h UIC was estimated and 
ranged from 147.3 to 156.2 µg/L (Perrine et al., 2014) and 24-h UIE estimates ranged 
from 145.7 to 163.3 µg/day. They were able to estimate 24-h UIE by multiplying I/Cr 
ratio by predicted 24-h creatinine excretion (Perrine et al., 2014). Interestingly, measured 
UIC and UIE do not fall within the estimated ranges, however they are very close in 
numbers. They concluded that the UIC in spot samples reasonably estimated UIC from 
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24-h samples; however, both were observed to be lower than UIE from 24-h urine 
samples. On average, iodine concentrations in spot urine samples did not differ compared 
to iodine concentrations from 24-h urine samples (Perrine et al., 2014).  
Doenyas-Barak et al. (2015) evaluated the use of multiple timed spot urine 
collections for measurement of daily sodium and potassium excretion. They found that 
sodium and potassium measured in spot collections can adequately estimate 24-h urine 
excretion. Participants (n=50) collected 24-h urine and were instructed to provide a 10 ml 
urine sample at 12:00 pm (spot 1), 4:00 pm (spot 2), 8:00 pm (spot 3), and from the final 
void collection the following morning (spot 4). Sodium, potassium, chloride, and 
creatinine excretion levels were measured in 24-h urine. The mean electrolyte level in 
each spot sample was expressed per gram creatinine. Expected creatinine excretion per 
day was calculated by the following equations: men = [28 - (age in years/6)] x weight 
(kg) and women = [22 - (age in years/9)]. Estimated sodium and potassium excretions 
were calculated for each spot and then correlated with the 24-h urine sodium and 
potassium excretion. They found a statistically significant linear correlation between 24-
hour urine excretion and the excretion estimated by any of the scheduled spot urine 
collections (sodium r = 0.51 to 0.68; potassium r = 0.53 to 0.75; chloride r = 0.34 to 0.51; 
for all p<0.05).  Yet, the average of the four spot urines was best correlated with the 24-
hour urine excretion. They reported that two to four spots collected throughout the day 
may strengthen the correlation to the 24-h urine excretion (Doenyas-Barak et al., 2015). 
Interestingly, sodium concentrations in morning spot samples had the highest correlation 
to the 24-h samples; whereas, potassium and chloride concentrations in afternoon spot 
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samples were better correlated.  They suggested collecting four spot samples as a 
convenient method for estimation of 24-hour excretion of sodium and potassium. 
 These findings demonstrate the practical implementation of spot urine samples 
for biomarker analysis. Because 24-hour urine collection is associated with high 
participant burden, finding an alternative way to measure excretion of sugars as a 
measure of intake will have great implications for the scientific community. No study 
thus far has investigated the uSF biomarker in spot urine. Determining the association 
between sugars biomarker in spot urine and sugars biomarker in 24-hour urine is the first 
step in validating the sugars biomarker in spot urine as a biomarker of intake. Using the 
spot urine measure in studying sugars-disease associations may have a great impact on 
elucidating the obscured association of sugars intake with risk of cancer, cardiovascular 
disease, type 2 diabetes, and other chronic disease. Reliably determining these 
associations is very important to help make stronger guidelines and reinforce 
recommendations. When sugar-disease associations are better understood, policies can be 
created to make healthier communities, disparities in consumption can be tackled, and 
education can be provided to parents to create a healthier environment for their children.  
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CHAPTER 3 
METHODS 
Participants 
 The study population included 15 participants age 22 to 49 years from an ongoing 
feeding study aimed to develop biomarkers of sugars intake (March 2016-July 2019) 
conducted in the Phoenix Metropolitan Area. Participants of the current study were 
recruited between March and August 2016. Inclusion criteria for study participation 
included being a non-smoker, age 18 and 70 years old, having a body mass index (BMI) 
of less than 35 kg/m2, having no known allergy to sunscreen or para-amino benzoic acid 
(PABA), being willing to refrain from taking dietary supplements over the 10-week study 
period, and residing in the Phoenix Metropolitan Area. Participants living or working 
within close proximity to the study center were given priority for participation, as there 
was a need for frequent visits to the study center. Exclusion criteria included presence of 
diseases that can affect nutrient absorption or metabolism, such as autoimmune diseases 
(e.g., type 1 diabetes, inflammatory bowel disease, celiac disease), endocrine (e.g., type 2 
diabetes, hyper or hypothyroidism), stomach disorders (e.g., ulcers, gastrointestinal 
bleeding), diseases that affect urine excretion (e.g., kidney disease, urinary incontinence), 
or requiring any dietary restrictions (e.g., celiac disease); participation in any diet related 
research study or trying to lose weight over the last four months; known allergy to 
sunscreen; and for women, being pregnant, breastfeeding, or planning to become 
pregnant in the next 15 weeks. Furthermore, people were considered ineligible if their 
fasting blood glucose or HbA1c were greater or equal to 100 mg/dl and 5.7% 
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respectively, based on the screening blood draw. The study was approved by Arizona 
State University Institutional Review Board (IRB) (Appendix A). 
 
Study recruitment 
Participants were recruited through various approaches. Recruitment tactics 
included posting flyers in ASU buildings (see Appendix B), advertising the study via the 
website www.sugarsbio.org and Facebook 
(https://www.facebook.com/asusugarsbio/?fref=ts), and through word of mouth.  
Prospective participants completed a preliminary screening questionnaire (see 
Appendix C) online or over the phone to determine eligibility based on the outlined 
inclusion and exclusion criteria. If potential participants passed the initial screening test, 
they were contacted by the project coordinator who then scheduled an in-person 
screening visit at the Arizona State University School of Nutrition and Health Promotion 
(ASU SNHP) study center in downtown Phoenix. During the screening in-person visit, 
the project coordinator described the study to the prospective participant in more detail 
using the information sheet (Appendix D). If the participant was still interested in 
participation, he/she then signed the consent form (see appendix E). During this visit, a 
fasting blood sample was collected for measurement of fasting blood glucose levels and 
HbA1c, and participant’s weight and height were taken for calculation of BMI. Once the 
fasting blood glucose and HbA1c were available, potential participants who met all the 
eligibility requirements, were scheduled for a baseline visit described below. 
A total of 34 potential participants were screened for the study between March 
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and August 2016.  Eleven were deemed ineligible due to unacceptable fasting blood 
glucose or HbA1c levels (n=8), participation in other diet related studies over the last 4 
months (n=1), supplement use (n=1), and thyroid disorder (n=1).  Out of 23 eligible 
individuals, one did not show up for the baseline visit, one participant was dropped from 
the study during the first food diary week because of non-compliance, and one withdrew 
because he was no longer interested in participating.  Therefore, 15 participants 
completed the entire protocol between March and August 2016, while the remaining five 
eligible participants were scheduled to complete the feeding protocol at a later date. 
 The recruitment of participants in the original ongoing feeding study was 
stratified by age (18-30, 31-43, 44-56, and 57-70 years), gender (male and female), and 
BMI (<25, 25-29.9, and 30-34.9 kg/m2) to ensure inclusion of participants with a wide 
range of sugars intake.  For a final sample of 107 participants in the ongoing feeding 
study, four participants need to be recruited in each age/gender/BMI stratum, and eleven 
randomly recruited in any of these strata. The stratification of the 15 participants of the 
current study has been reported in Table 1. 
Table 1. Stratification of the study population (n=15) 
 
Age 
groups 
BMI (kg/m2) 
< 25 25-29.9 30-34.9 
Men Women Men Women Men Women 
18-30 yrs 3 1 1   1 
31-43 yrs 2 3    1 
44-56 yrs  2  1   
57-70 yrs       
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Study design 
This was a highly controlled 15-day feeding study in which participants 
consumed their normal diet and collected eight, nonconsecutive, 24-hour urine samples 
(i.e., every other day) (see Appendix F for Study figure). On two out of the eight 24-h 
urine collection days, each urine void was collected in a separate container, resulting in a 
multiple spot urine collection. Additionally, three fasting blood samples were collected 
from each participant before the start, upon completion, and 5 weeks following 
completion of the feeding period. During the 15-day study, participants only consumed 
food and beverages provided to them by the study center, except black tea, black coffee, 
and alcohol.  
 
Baseline visit 
The baseline visit took approximately one and a half hours. During this visit, a 
baseline questionnaire was administered gathering information on demographics, lifestyle 
habits, and personal medical history (see appendix G). Upon completion of the 
questionnaire, a detailed overview of the study was given by one of the research team 
members, including detailed instructions for completion of the urine collection and 
feeding protocols. All study forms (urine collection logs, meal checklist and physical 
activity log) were reviewed and explained in detail. Any questions or concerns regarding 
the study protocol or the policy for consuming no outside foods or beverages were 
addressed at this visit.  
To assess and replicate participants’ habitual diet, participants completed two 
consecutive 7-day food records prior to the commencement of the feeding protocol. In 
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two 7-day increments, participants wrote down all foods and beverages they consumed 
over 7 days, providing details on quantities, brand information, cooking methods, and 
recipes. During the baseline visit, the research chef trained participants on how to keep a 
food diary over the following two weeks (see appendix H), and provided them with 
measuring tools and a Food Model Booklet (FMB) (Beltsville Human Nutrition Research 
Center, July 2007) to help them determine and record quantities. The USDA FMB 
contains life size, two-dimensional drawings of foods and utensils, to help participants 
more accurately estimate the amount of food consumed. Participants were instructed to 
maintain their usual dietary behavior during this two-week recording period.  
Upon completion of each 7-day food diary, a meeting with the research chef was 
scheduled to review the food diary and obtain more detail on the foods, participants’ 
dietary habits, and cooking practices. These two 7-day food diaries were then used to 
replicate participants’ usual diet, and mimic their habitual eating patterns during the 15-
day feeding period. One week after the second food diary was completed, which was 
used to purchase all the food and start preparing the daily meals, the participants began 
the 15-day feeding period. 
 
Feeding protocol 
The 15-day feeding period was the highly controlled portion of the study wherein 
participants received all their foods from the metabolic kitchen in the study center. No 
consumption of outside foods or beverages was allowed over the 15-d feeding period, 
besides black coffee, tea, and alcohol (wine, beer or hard liquor only). During the 15 
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days, participants came to the study center Monday to Friday to consume their breakfast, 
and to collect the rest of the meals for the day. To lessen participants’ burden, all the 
meals for the weekend were collected on Fridays and consumed at home. Upon arrival at 
the study center Monday to Friday, participants weight was measured and recorded 
before consumption of breakfast, and monitored throughout the study to ensure that 
participants were weight stable and in energy balance.  
All meals, snacks, and beverages, besides water, for that day were prepared, 
carefully weighed, labeled with participant ID, and provided to the participant in a cooler 
trolley for ease of transport. Instructions on how to reheat the meals along with food 
safety information were also given to participants. While participants were free to eat as 
much as they wanted from the provided food, they were asked to keep all leftovers and 
unconsumed foods in their respective container and return them to the study center the 
following day. All the returned food was then carefully weighed to the nearest gram, 
which allowed the metabolic kitchen to determine the exact amount of food consumed.  
For each of the 15 days, energy and nutrient intake were calculated using the 
Nutrition Data System for Research (NDS-R), Version 2016, Nutrition Coordinating 
Center [NCC], Minneapolis, MN. The NDS-R food composition information database 
draws from the USDA Nutrient Data Laboratory composed of over 18,000 foods, almost 
half of which are brand name items (University of Minnesota, Nutrition Coordinating 
Center (NCC).  However, no dietary intake data were used for the purposes of the thesis. 
 
Meal checklist 
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To monitor compliance to the feeding protocol, participants were asked to 
complete a meal checklist daily, throughout the 15-day feeding period (see Appendix I). 
Participants checked a box for each meal and snack consumed, recorded the time of each 
meal/snack, noted any deviation from the feeding protocol (amount of any unconsumed 
food that was not returned, or food that was consumed that was not provided by the 
metabolic kitchen), and recorded type and amount of alcohol, tea and coffee consumed. 
 
Blood collection 
Three fasting blood samples were taken during the 10-week study period; on the 
first day of the feeding period, the morning following the completion of the feeding 
period, and five weeks after the last day of the feeding period. The blood samples will be 
used to measure another biomarker of sugars intake, which is outside the scope of this 
thesis. 
 
Physical activity assessment 
 During the 15-day feeding period, participants recorded their physical activity 
daily using a validated physical activity (PA) log (see Appendix J). The log contains 48 
items of occupational, transportation, home, conditioning, sports, and leisure activities. 
Participants were instructed to record the number of minutes and hours doing each 
activity and the time the activity began in this PA log.   
 
Urine collection protocol 
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During the 15-day feeding period, participants collected 24-h urine every other 
day starting with day 1 (i.e., day 1, 3, 5, 7, 9, 11, 13, 15 of the study). Participants were 
instructed to discard the first morning urine void, and from there on to collect all 
subsequent voids, and end the collection with the first morning void of the following day.  
The day preceding the collection of urine, participants were given a urine 
collection kit comprised of Directions for Collecting 24-hour Urine Sample (see 
appendix K), a 24-h urine collection log (see appendix L), and a trolley cooler, which 
included two three-liter urine collection containers containing approximately 4 g of boric 
acid each as a urine preservative (for a final concentration of boric acid of 2 g/L assuming 
collection of 2 L urine per container); collection hat (for females) or urinal (for males); 
three POTABA tablets and a funnel.  Because the sugars in the urine are sensitive to 
higher than room temperature, participants were asked to keep the collection container(s) 
in the provided cooler with ice packs, in order to keep the urine under 22°C. Temperature 
above 22°C may promote microbial growth and compromise sucrose and fructose 
integrity in the urine samples (Tasevska N, personal communications). A temperature 
logger was kept in the cooler to track any changes in temperature.  
To ease participants’ burden, a courier service was organized to collect urine 
samples from participants’ homes.  After participants collected their last urine void on the 
following morning, they were asked to place their cooler trolley with urine samples 
outside their place of residence to be picked-up and delivered directly to the study center.   
During weekends, the specimens were kept at the courier’s facilities under refrigeration, 
and delivered to the study center on the next business day.  
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During each 24-h urine collection day, participants kept a 24-hour Urine 
Collection log (see Appendix L), logging the time of the first morning void they 
discarded, the time of the second morning void (i.e., the first void of the 24-h urine 
collection), and the first morning void of the following day (i.e., the last void of the 24-h 
urine collection); time when the POTABA capsules were taken; and information on any 
missed urine (approximate amount ant time), and medications taken during the collection 
period (name, brand and dose). 
 
Multiple spot urine collection protocol 
On two of the eight 24-hour urine collection days, participants were asked to 
collect each urine void in a separate container. These urine voids collected over a 24-h 
period are called multiple spot urine collections. Similar to a 24-hour urine collection 
day, on the multiple spot urine collection day, participants discarded the first morning 
void, collected all urine voids thereafter, and ended the collection with the first morning 
void of the following day; however, each void was collected into a separate container. 
For this purpose, participants were given twelve small containers, six one-liter 
(containing 1 g boric acid) and six 500 ml (containing 600 mg boric acid) in a trolley 
cooler with ice packs. They also received Directions for Collecting Multiple Spot Urine 
Sample (see Appendix M), Multiple Spot Urine Collection log (see Appendix N), 
collection hat or urinal, a funnel, and three POTABA tablets (see below). On these two 
days, participants were instructed to record the time of each individual void on the urine 
collection container, as well as on the Multiple Spot Urine Collection log.  In addition, 
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they logged the time when the POTABA capsules were taken; time of the discarded first 
morning void; and information on any missed urine (approximate amount and time), and 
medications taken during the collection period (name, brand and dose). Containers were 
kept in a cooler with frozen ice packs at all time, in order to ensure storage temperature of 
under 22°C.  Upon collection of the last spot urine void on the following morning, 
participants were asked to place their cooler trolley with samples outside their place of 
residence for the courier to pick up.  
 
Marker for 24-hour urine completeness 
To assess completeness of the 24-hour urine collections, participants were asked 
to take three 102 mg tablets of potassium para-amino benzoate (POTABA) on each urine 
collection day. These capsules contain a daily dose of 240 mg of PABA (80 mg PABA 
per capsule), which is a known marker for 24-hour completeness (Bingham & 
Cummings, 1983) commonly used in dietary biomarker studies (Subar et al, 2013).  
Given pharmaceutical-grade PABA is not available in the U.S., research has been 
performed to determine if POTABA, the potassium salt of PABA, can be used (Sharma et 
al., 2014).  This study (n=20) analyzed 24-h urine collections and determined the 
recovery of PABA after POTABA administration was 95%, indicating that POTABA can 
be used as an alternative (Sharma et al., 2014). Participants were instructed to take the 
tablets spread out during the day, within scheduled time intervals (with breakfast, lunch 
and dinner). Reminders were sent to the participants via email or text, to ensure that they 
did not forget or delay taking of the tablets. Minimal side effects, such as skin allergy and 
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upset stomach, have been reported from taking PABA. To prevent the occurrence of 
adverse effects, participants with known allergies to PABA or sunscreen (as PABA used 
to be a common ingredient of sunscreen) were not be eligible to participate. Because 
some medications, such as acetaminophen (Tylenol), sulphonamides, furosemide (Lasix), 
have similar structure to PABA and may interfere with measurement of PABA, 
participants were instructed to refrain from taking these medications, if possible. If any 
medications had to be taken by the participant, they were asked to record the type of 
medication, brand and the amount in the 24-h Urine Collection or Multiple  
Spot Urine Collection log. 
For urine to be considered a complete collection, it is expected that 85-110% of 
the orally administered PABA will be recovered in the 24-hour urine collection. PABA 
was measured on Gentek Synergy H1 spectrophotometer using colorimetric technique as 
previously described (Bingham & Cummings, 1983). Urine collections with PABA 
recovery <85% were excluded from the analysis as incomplete.  PABA recovery >110% 
often indicates that the participant took medications that have similar structure to PABA, 
which cannot be distinguished by the colorimetric method.  In such cases, urine 
collections were reanalyzed using a High Performance Liquid Chromatography (HPLC) 
method (Jakobsen et al., 1997), which is more specific and can separate PABA from 
similar compounds.  Urine with PABA recoveries lower than 78% as measured by the 
HPLC were considered incomplete (Jakobsen et al., 2003).  Percent PABA recovery was 
calculated as concentration of PABA in urine mg/L x 24-h urine volume (L)/2.4. 
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Urine Processing Protocol 
 The day following the urine collection day, the urine was delivered to the study 
center by the courier and was stored for maximum of 4 hours at 4°C until processing. For 
processing, 24-hour urine samples were weighed, thoroughly mixed at least twenty times 
with rotation and inversion, immediately aliquoted into multiple vials, and stored at          
-20°C and -80°C for further analyses.   
 The multiple spot urine collections were similarly processed; each separate void 
was weighed, thorough mixed, aliquoted into multiple vials, and stored at -20°C and -
80°C for further analyses. In addition, a composite of a 24-hour urine was created from 
the multiple spot voids, by mixing 10% of each void volume in a single container. The 
container was then thoroughly mixed, aliquoted, and vials stored at -20°C and -80°C.  
 
Laboratory analysis of sucrose and fructose in urine 
Urinary sucrose and fructose (uSF) were measured in multiple spot urine voids 
and the corresponding 24-h composite urine (Spot Day 1 and Spot Day 2). USF 
concentrations (mg/L) were measured on a Beckman DU 730 Life Sciences UV/Vis 
spectrophotometer, using a colorimetric enzymatic assay (Sucrose/D-Glucose/D-
Fructose; Biochemica Mannheim, R-Biopharm, Roche; http://www.r-biopharm.com/ 
catalogue no. 10716260035) (Appendix O).  
The colorimetric enzymatic assay for analysis begins with sucrose being 
hydrolyzed by fructosidase to D-glucose and D-fructose. D-glucose is then 
phosphorylated by ATP to D-glucose-6-phosphate (G-6-P), and D-fructose is 
phosphorylated by ATP to D-fructose-6- phosphate (F-6-P), both reactions catalyzed 
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by hexokinase. Phosphoglucose isomerase (PGI), which converts F-6-P to G-6-P, is then 
added. In the presence of nicotinamide adenine dinucleotide phosphate (NADP), G-6-P is 
oxidized, while NADP is reduced to NADPH. The Beckman DU 730 Life Sciences 
UV/Vis spectrophotometer set at 340 nm measures the amount of NADPH by light 
absorbance proportional to the amount of D-glucose. This value is then the basis to 
determine the concentrations of sucrose, fructose and glucose. D-glucose is determined 
before and after the enzymatic hydrolysis of sucrose. Finally, the sucrose concentrations 
can be calculated from the difference of the D-glucose concentration before and after β-
fructosidase is added, whereas fructose from the difference of the D-glucose 
concentration before and after PGI is added.  
Samples to be analyzed were retrieved from the freezer, and thawed out within 
one hour of analysis. Next, standards of 5 mg/L, 50 mg/L, and 100 mg/L of sucrose, 
fructose, and glucose were prepared with Milli-Q (MQ) water using fructose (Sigma D-
Fructose), sucrose (R-Biopharm Sucrose assay control material), and glucose (Sigma D-
Glucose, minimum 99.5%). All standards were labeled, kept in the refrigerator and 
remade on a monthly basis.  
Ten ml of MQ water was added to Bottle 1 from the kit to create Solution 1 
(fructosidase), mixed well, and left out to reach room temperature. Forty-five ml of MQ 
water was added to Bottle 2 to create Solution 2 (NADP). Bottle 3, containing 1.1 ml 
suspension of hexokinase (320 U) and glucose-6-phosphate dehydrogenase (160 U), and 
bottle 4, 0.6 ml phosphoglucose isomerase suspension (420 U), were kept at 4°C.  
Samples were ran in duplicates and each participant’s samples were analyzed in 
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the same run. Up to 14 samples can be ran in one run, however samples were organized 
to keep the runs at an ideal range of 7-10 samples per run. Depending on how many 
multiple spot voids each participant had, on average it took two runs per participant, 
keeping samples from the same multiple spot collection day in the same run. 
In preparation to run the urine samples, cuvettes were prepared for each sample. 
Cuvettes in duplicates were labeled, one set for sucrose determination and another set for 
glucose/fructose determination. This totals to four cuvettes for each sample (two sucrose 
and two glucose/fructose cuvettes), the blank, 5 mg/L, 50 mg/L, and 100 mg/L standards, 
and a quality control (QC).  A QC was created from a pooled urine sample preserved 
with boric acid from volunteers who had taken 3 x 102 mg POTABA tables, stored as 
single-use aliquots at -80°C, and included in every run.   
The solutions were added in order as shown in Table 2.   
 
Table 2: Protocol for colorimetric determination of sucrose, glucose and fructose  
 Blank/Sucrose sample 
(ml) 
Blank/Glucose/Fructose sample 
(ml) 
Solution 1*  
Sample 
0.2 
0.5 
 
0.5 
Mix, incubate for 15 min. *Bring Solution 1 and 2 to room temperature◦C 
before use.  Then add 
Solution 2* 
MQ Water 
1.0 
1.3 
1.0 
1.5 
Mix, and after 3 min read absorbance (A) 1   
Bottle 3 0.02 0.02 
Mix, and after 15 min read A2 
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Bottle 4  0.02 
Mix, and after 15 min read A3 
*Solution 1 (fructosidase), solution 2 (NADP), solution 3 (suspension of hexokinase, 
320 U, and glucose-6-phosphate dehydrogenase, 160 U), and solution 4 
(phosphoglucose isomerase suspension 420 U). 
 
To begin the analysis, 0.2 ml of fructosidase was added to the cuvettes prepared 
for sucrose determination. Next, 0.5 ml of each standard and each urine samples, were 
pipetted into the respective cuvettes. Plastic mixing sticks were placed in all sucrose 
cuvettes and the content was thoroughly mixed. The timer was set for 15 minutes. Then, 
using the repeater pipette, 1.0 ml of Solution 2 (NADP) was added to all the cuvettes. 
This was repeated adding 1.3 ml of MQ water to the sucrose cuvettes and 1.5 ml to the 
fructose cuvettes. The content was mixed again using the mixing sticks. The timer was 
set for 3 minutes, after which the first absorbance (A1) was read on 340 nm. Next, 0.02 
ml of Bottle 3 (hexokinase) was added to each cuvette, using the pipette tip to mix the 
content. Fifteen minutes following the addition of hexokinase, second absorbance (A2) 
was read. Lastly, 0.02 ml of Bottle 4 (PGI) was added to only the glucose/fructose 
determination cuvettes, mixed, and left for 15 minutes. Final absorbance (A3) was then 
read and recorded. All absorbance data were entered into an excel sheet and using the 
equations shown below, concentrations of sucrose, fructose, and glucose in the urine 
were calculated.  
∆Asucrose = [(A2 – A1)sample – (A2 – A1)blank]  
 
C = concentration (mg/L) 
V = final volume (ml) 
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v = sample volume (ml) 
MW = molecular weight of the substance to be measured (g/mol) 
d = light path of the instrument (cm), which equals the distance from bottom of the well 
to the upper surface of the final volume. 
ɛ = extinction coefficient of NADPH, which for 340 nm = 6.3 [l x mmol-1 x cm-1]  
 
 
 
∆Aglucose = (A2 – A1)sample – (A2 – A1)blank 
∆Afructose = (A3 – A2)sample – (A3 – A2)blank 
 
 
 
 
 
The limit of detection for this method is 0.4 mg for D-glucose and D-fructose, and 
2 mg of sucrose.  
The mean ± SD of sucrose and fructose concentration of the QC was 15.9 ± 0.75 
mg/L and 10.48 ± 0.25 mg/L, respectively, based on nine QC samples analyzed in a 
single run.   The acceptable range for the QC was set at +/- 10% of the mean, and it was 
14.27-17.47 mg/L for sucrose, and 9.43-11.53 mg/L for fructose.  One QC in duplicate 
was included in each run. If any of QCs produced sucrose or fructose concentrations 
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outside of the acceptable range, the run was repeated. Additionally, samples were 
reanalyzed if the % Coefficient of Variation (CV) for the duplicates (SD/mean x 100) fell 
within the following criteria: sucrose concentration (mg/L) of 5-10 mg/L with a 
%CV>20%, 10-20mg/L with a %CV>15%, 20-30 mg/L with a %CV>10%, and greater 
than 30 mg/L with a %CV>5%; fructose concentration (mg/L) of less than 10 mg/L with 
a %CV>20%, 10-15 mg/L with a %CV>10%, and greater than 15 mg/L with a 
%CV>5%. 
  The mean inter-assay %CV for the QC was 10.9% for sucrose and 4.0% for 
fructose.  The mean intra-assay %CV for the QC was 5.3% for sucrose and 2.6% for 
fructose.  
 
Creatinine determination 
Creatinine was measured in each urine void (g/L) on a Cobas C111 analyzer, 
using a kinetic colorimetric assay using the Jaffe method, CREJ2 Roche (Roche 
Diagnostics; Catalog Number: 06407137190). Determination of creatinine is based on the 
rate of dye formation, as the yellow-orange complex is proportional to the amount of 
creatinine in the urine sample. To minimize the quantification of similar compounds, 
including proteins and ketones, creatinine concentrations are adjusted by 0.2 mg/dL. 
Using this method, the lower detection limit is 0.31 mg/dL. Each urine sample was 
loaded into the systems cuvettes and ran in duplicates. The mean %CV for the duplicates 
was 1.71%.  Any samples with a %CV greater than 5% were reran.  
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Statistical analysis  
The amount of sucrose and fructose excretion in 24-h urine (mg/day) was 
calculated by multiplying the measured concentration in mg/L with the 24-h urine 
volume (L).  Similarly, sucrose and fructose excretion per void was calculated by 
multiplying measured concentration in mg/L with the volume of each spot urine (L).  
Urinary sucrose and fructose per void was also expressed per gram creatinine, and was 
calculated as sucrose and fructose concentrations (mg/L) divided by the respective 
creatinine value (g/L). Sucrose and fructose amounts in urine were summed and denoted 
as uSF thereafter. 24-h uSF concentrations were initially measured in the corresponding 
24-h composite urine; however, we used 24-h uSF (mg/day) calculated by summing uSF 
excretion in the multiple spot voids (mg/void) for each spot day (i.e., spot day 1 and spot 
day 2).  
Due to the variability in the number of multiple spot voids per day each 
participant had, four timed spots were identified in order to standardize their number 
between subjects and run statistical analyses.  The definition previously used in 
NHANES (Wang et al., 2013) to identify four timed spots out of all collected voids was 
modified to include meal time.  The first void collected after breakfast or between 8:30 
am-12:30 pm was identified as the morning void; afternoon void was the first void 
collected after lunch or between 12:31 pm-5:30 pm; evening void was the first void after 
dinner or between 5:31 pm-12:00 am; next day void was the first morning void and 
between 4:00 am-12:00 pm. 
The distributions of all continuous variables were checked by the Shapiro-Wilk 
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test. If variables had skewed distributions, each variable was either log 10 or square root 
transformed to achieve normal distribution (Table 3).  
Table 3: Normality distribution check of variables 
Variable Spot day 1 Spot day 2 Two day 
mean 
24-h excretion of sucrose and 
fructose (mg/day) 
ND* ND* ND* 
24-h urine volume (ml) ND* ND* ND* 
24-h PABA % recovery (HPLC) ND* ND* ND* 
24-h PABA % recovery (Spec) ND* Log10 ND* 
Number of voids per subject (n) ND* ND* ND* 
Morning void sucrose and fructose 
excretion (mg/void) 
Sqrt Log10 Sqrt 
Afternoon void sucrose and 
fructose excretion (mg/void) 
Log10 Log10 Log10 
Evening void sucrose and fructose 
excretion (mg/void) 
Log10 Log10 Log10 
Next day sucrose and fructose 
excretion (mg/void) 
Log10 Log10 Log10 
Morning void sucrose and fructose 
excretion (mg/g creatinine) 
Log10 Log10 ND* 
Afternoon void sucrose and 
fructose excretion (mg/void) 
Log10 Log10 Log10 
Evening void sucrose and fructose 
excretion (mg/void) 
ND* Log10 Log10 
Next day void sucrose and fructose 
excretion (mg/void) 
Log10 Log10 Log10 
Morning void volume (ml) ND* ND* ND* 
Afternoon void volume (ml) Log10 ND* Log10 
Evening void volume (ml) Log10 ND* ND* 
Next day void volume (ml) ND* Log10 ND* 
Morning void minutes since last 
meal (minutes) 
ND* ND* ND* 
Afternoon void minutes since last 
meal (minutes) 
ND* Log10 ND* 
Evening void minutes since last 
meal (minutes) 
Log10 Log10 Log10 
Next day void minutes since last 
meal (minutes) 
ND* ND* ND* 
* ND - normal distribution 
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Mean and standard deviations (SD) were calculated for normally distributed 
continuous variables, and medians and interquartile range (IQR) for continuous variables 
with skewed distributions.  
To ensure energy balance was maintained during the feeding period, participants’ 
body weights (kg) were measured and recorded daily. A paired samples t test was run to 
determine if there was a difference in body weights (kg) before and after the 15-day 
feeding period, indicating energy balance or imbalance.  
To investigate if there is a difference in uSF excretion (mg/void and mg/g 
creatinine) between the four timed urine voids, a Wilcoxon non-parametric test was 
performed.  To control for multiple comparisons (6 comparison tests), we used 
Bonferroni correction, which sets a more conservative significance cut-off at α/n, where α 
is Type 1 error (0.05) and n is number of tests/comparisons; the cut off was p<0.008.   
Within and between subject variability in uSF excretion (mg/void) and uSF 
excretion (mg/g creatinine) were calculated for the identified timed urine voids using 
%CV (CV% = SD/mean x 100) and variance (VAR = SD2). Within subject (WS) 
variability measures day-to-day variability in uSF excretion within participants, whereas 
between subject (BS) variability measures variability in uSF excretion between 
participants in a group. Each participant’s mean values were calculated by averaging spot 
day 1 and spot day 2 values, then SDWS, %CVWS and VARWS were calculated from the 
same values. The participants’ mean values were averaged to create the group mean. A 
SDBS was calculated from these means, then allowing %CVBS and VARBS to be 
calculated. A ratio of within subject and between subject variance (VARWS/VARBS) was 
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used to determine if within subject variance is greater or smaller than between subject 
variance in excretion.  
Pearson correlation coefficient was used to determine if there is an association 
between spot void uSF excretion and 24-h uSF excretion; correlations were determined 
between timed urine voids and 24-h urine collection for uSF excretion (mg/void) and uSF 
excretion (mg/g creatinine).  
Lastly, multiple linear regression models were run to determine the predictive 
ability of sucrose and fructose excretion in timed spot collection and other covariates on 
24-h uSF excretion. The dependent variable was 24-h sucrose and fructose excretion 
(mg/day), whereas uSF in timed spot voids (mg/void or mg/g creatinine) was run as the 
independent variable.  Multiple covariates in addition to uSF excretion in timed spots 
(mg/void and mg/g creatinine) were included in the models. These included age (years), 
BMI (kg/m2), gender, time since last meal (minutes), and void volume (ml).  Time since 
last meal was calculated by counting the minutes between the time of the identified void 
and the time of the last meal recorded in the meal checklist.  Covariates were included in 
the final model only if they were statistically significant predictors of 24-h uSF excretion 
or they strengthened the adjusted R2 value of the final model. Models were run for spot 
day 1, spot day 2, and two-day mean 24-h uSF excretion. We report adjusted R2 for the 
final model, and beta coefficient and standard error (SE) for each independent variable.  
A higher R2 means that the dependent variable, 24-h uSF is better predicted or had a 
higher proportion of its variability explained by the independent variables, the predictors.  
All the analyses were conducted using SPSS Statistical Software (version 24.0; 
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Armonk, NY: IBM Corp). P values less than 0.05 were considered statistically 
significant. 
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CHAPTER 4 
RESULTS 
Fifteen participants completed the entire protocol between March and August 
2016. Twelve participants collected complete 24-h urine collections during the two 
multiple spot urine collection days (multiple spot urine collection day 1 and 2). One 
participant self-reported one missed void for multiple spot urine collection day 2.  Based 
on PABA, multiple spot urine collection 2 was found to be incomplete for one 
participant, and for one participants, both multiple spot urine collections were 
incomplete.  Hence, one participant was excluded from all the analyses, and for two 
participants, only data from one multiple spot urine collection day were used. 
Table 4 describes the study population demographics (n=14). Study population 
included eight females and six males with mean age of 34.3 years (SD=9.4 years).  
Table 4: Study population demographics (n=14) 
Demographic characteristic Means ± SD (range) or n (%) 
Gender Male 6 (42.9%) 
 Female 8 (57.1%) 
Age  Years 34.3 ± 9.4  
(23.0-53.0) 
BMI  kg/m2 24.2 ± 3.5 
(17.9-30.7) 
Ethnicity White 11 (78.6%) 
 Hispanic/Latino 2 (14.3%) 
 Asian 1 (7.1%) 
Income Less than 
$44,999 
9 (64.3%) 
 $45,000-104,999 3 (21.4%) 
 More than 
$105,000 
2 (14.3%) 
Occupation Student 8 (57.1%) 
 Academic fields 4 (28.6%) 
 Tech and lab 2 (14.3%) 
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Marital 
status 
Single 8 (57.2%) 
 Married/living 
with partner 
5 (35.7%) 
 Divorced 1 (7.1%) 
 
The mean BMI (kg/m2) was 24.2 kg/m2 (SD=3.5); ten participants were normal weight 
(BMI of < 25 kg/m2), two participants were overweight (BMI of 25-29.9 kg/m2), and two 
participants were obese (BMI of 30-34.9 kg/m2). Further study population demographics 
are presented in Table 4. Table 5 reports the study participants’ body weight at the 
beginning and at completion of the 15-d feeding period. The mean difference in body 
weight between pre- and post-feeding was 0.57 kg, and was not statistically significant 
(t=1.76; p=0.102). 
Table 5: Participants’ body weight (BW) measured before and after the 15-day feeding 
period (n=14) 
Participant 
Pre- feeding 
BW (kg) 
Post- feeding 
BW (kg) 
BW 
difference* 
SB001 67.8 68.2 0.4 
SB002 66.0 64.8 -1.2 
SB003 60.8 58.5 -2.3 
SB004 71.4 70.5 -0.9 
SB005 63.2 63.2 0 
SB007 90.4 92.5 2.1 
SB008 82.7 83.0 0.3 
SB009 69.0 68.6 -0.4 
SB010 54.5 54.0 -0.5 
SB011 66.7 66.3 -0.4 
SB012 64.5 63.0 -1.5 
SB013 79.0 79.3 0.3 
SB014 81.2 78.6 -2.6 
SB015 79.0 77.7 -1.3 
Mean 71.2 70.6 -0.57 
* Difference between pre and post body weight was investigated using a paired t test: t=1.76 
; p= 0.102. 
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Table 6 reports descriptive statistics of spot void collections made during 
multiple spot urine collection day 1 and 2. The two-day mean 24-h urine volume 
collected by the study population was 2825.4 ml (SD= 1291.7 ml), whereas the average 
void volume per participant was 365.3 ml (SD=48.7 ml). On average, 7.2 urine voids/day 
were collected per participant (range: 3 - 10).  
 
Table 6: Descriptive statistics of spot void collections made during multiple spot urine 
collection day 1 and 2 (n=14) 
 n Spot day 1 n Spot day 2 Two-day 
Mean 
Total 24-h urine 
volume (ml) 
14 2973.4 ± 
1405.0* (726.2 
– 5059.5)† 
12 2580.0 ± 
1168.8* 
(1165.1 – 
4484.5) 
2825.4 ± 
1291.7* 
(1078.1 – 
4811.5) 
Number of voids 
per subject (n) 
14 7.0 ± 2.0* 
(4.0 – 10.0) 
12 7.5 ± 1.9* 
(3.0 – 10.0) 
7.2 ± 1.7 * 
(3.0 – 10.0) 
Void volume per 
subject (ml) 
14 399.7 ± 173.8* 
 
12 330.8 ± 111.1* 
 
365.3 ± 48.7* 
 
Timed void volume (ml)     
Morning 14 350.7 ± 236.2* 
(114.6 – 
847.8) 
11 313.1 ± 171.4* 
(55.8 – 584.9) 
314.1 ± 195.5* 
(90.2 – 716.4) 
Afternoon 14 428.0 ± 385.4 
(197.8 – 
1016.0) 
11 270.7 ± 163.8* 
(100.7 – 605.8) 
359.8 ± 270.5 
(159.7 – 
1016.0) 
Evening 14 331.4 ± 372.9 
(135.9 – 
128.5) 
12 353.2 ± 159.0* 
(136.4 – 682.7) 
409.8 ± 216.1* 
(175.6 – 
826.1) 
Next day 14 508.7 ± 177.8* 
(268.0 – 
843.3) 
12 400.4 ± 423.0 
(255.6 – 
1230.6) 
509.1 ± 192.9* 
(286.7 – 
980.5) 
Time since last meal 
(min) 
    
Morning void 14 87.4 ± 53.0*  
(0.0 – 195.0) 
11 85.2 ± 57.7*  
(1.0 – 210.0) 
88.2 ± 45.0* 
(22.5 – 197.0) 
Afternoon void 14 111.5 ± 83.8*  
(0.0 – 330.0) 
11 59.0 ± 105.0 
(6.0 – 285.0) 
93.1 ± 45.2*  
(15 – 170.5) 
Evening void 14 60.5 ± 83.0 
(9.0 – 229.0) 
12 41.0 ± 56.3 
(5.0 – 335.0) 
55.3 ± 84.3 
(11.5 – 229.0) 
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Next day void 14 606.8 ± 134.9* 
(385.0 – 
872.0) 
12 598.8 ± 91.0* 
(415.0 – 717.0) 
603.9 ± 109.7* 
(425.0 – 
794.5) 
Para amino benzoic 
acid (PABA) recovery 
in 24-h urine 
    
HPLC 
measurements (%) 
14 93.9 ± 8.0* 
(78.6 – 107.5) 
14 84.9 ± 10.1* 
(60.9 – 99.6) 
89.4 ± 6.9* 
(75.1 – 99.8) 
SPEC 
measurements (%) 
14 103.9 ± 10.5* 
(87.6 – 128.1) 
14 103.0 ± 25.0 
(57.0 – 200.2) 
108.6 ± 17.4* 
(74.5 – 147.7) 
*Indicated values are means ± SD, and all other values are median ± IQR 
† Range all such values. 
 
The volume of individual spot voids ranged from 22.8 to 1280.5 ml, and among timed 
voids, it was largest for the next day void (Table 6). Time (minutes) since last meal were 
determined for each of the timed urine voids. The two-day mean minutes since last meal 
were 88.2, 93.1, 55.3 and 603.9 minutes for morning, afternoon, evening, and next day 
void, respectively.  The two-day mean PABA recovery was 89.4% (SD=6.9%) by the 
HPLC method, and 108.6% (SD=17.4%) by the spectrophotometric method (Table 6).  
The uSF excretion in 24-h urine (mg/day) and timed spot collections (mg/void) 
during spot day 1 and spot day 2, and respective two-day mean values, are reported in 
Table 7. The two-day mean uSF was 50.6 mg (SD=29.5) for 24-h urine, and 7.5 
(IQR=14.0), 4.5 (IQR=8.5), 5.1 (IQR=7.1), and 4.6 (IQR=12.3) mg for morning, 
afternoon, evening, and next day void, respectively. There were no statistically 
significant differences in uSF excretion level between the timed spot voids for spot day 1, 
spot day 2, and the two-day mean as tested by the Wilcoxon non-parametric test (Table 
7).   
Table 7: Sum of sucrose and fructose excretion (uSF) in 24 hour urine (mg/day) and 
timed spot urine collections (mg/void) during multiple spot urine collection day 1 and 2 
(n=14)† 
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 n Spot day 1 n Spot day 2 n Two day 
mean 
uSF in 24 hour 
urine (mg/day) 
14 43.5 ± 
28.5*1 
12 62.5 ± 
44.3*1 
14 50.6 ± 29.5*1 
uSF in morning 
void (mg/void) 
14 6.4 ± 5.71 11 4.4 ± 9.61 14 7.5 ± 14.01 
uSF in afternoon 
void (mg/void) 
14 3.6 ± 7.21 11 4.7 ± 11.71 14 4.5 ± 8.51 
uSF in evening  
void (mg/void) 
14 3.6 ± 10.11 12 3.7 ± 9.41 14 5.1 ± 7.11 
uSF in next day 
void (mg/void) 
14 5.0 ± 9.11 12 3.8 ± 10.71 
 
14 4.6 ± 12.31 
*Indicated values are means ± SD, and all other values are median ± IQR. 
† Wilcoxon test performed with Bonferroni adjustment (p<0.008) to test the difference in 
excretion by column.  Values marked with the same numeric superscript are not statistically 
significantly different from each other. 
 
Table 8 describes the uSF excretion in timed spot collections during spot day 1 
and spot day 2, and two-day mean values expressed per gram creatinine. The two-day 
mean uSF was 60.2 (SD=39.9), 25.5 (IQR=40.2), 32.6 (IQR=38.2), and 12.3 (IQR=18.9) 
mg/g creatinine for morning, afternoon, evening, and next day void, respectively. Using 
the Wilcoxon non-parametric test, we found no statistically significant difference in uSF 
excretion (mg/gram creatinine) between any of the timed spot voids for spot day 1 and 
spot day 2.  When we compared the two-day mean uSF excretion per gram creatinine 
among the four timed spot voids, we only found a statistically significant difference 
between uSF excretion in the morning and next day void (Z = -2.794, p=0.005). 
Table 8: Sum of sucrose and fructose excretion (uSF) per gram creatinine in timed spot 
urine collections during multiple spot urine collection day 1 and 2 (n=14)† 
 n Spot day 1 n Spot day 2 n Two day 
mean 
uSF in morning 
void  
(mg/g creatinine) 
14 37.3 ± 
69.5*1 
11 56.1 ± 
80.6*1 
14 60.2 ± 39.91 
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uSF in afternoon 
void (mg/g 
creatinine) 
14 23.3 ± 
23.2*1 
11 40.7 ± 
76.8*1 
14 25.5 ± 40.2*1,2 
uSF in evening 
void 
(mg/g creatinine) 
14 33.6 ± 
29.41 
12 22.3 ± 
33.3*1 
14 32.6 ± 38.2*1,2 
uSF in next day 
void 
(mg/g creatinine) 
14 12.3 ± 
20.2*1 
12 8.7 ± 22.6*1 14 12.3 ± 18.9*2 
*Indicated values are median ± IQR, and all other values are means ± SD. 
† Wilcoxon test performed with Bonferroni adjustment (p<0.008), to test the difference in 
excretion by column.  Values marked with the same numeric superscript are not statistically 
significantly different from each other. 
 
The uSF excretion by spot void for each participant by spot day 1 and 2 are shown 
in Appendix P. No particular trends in uSF excretion by spot void were observed. 
Overall, the majority of participants had low uSF excretion. Eleven out of the 14 
participants had less than 45 mg/void uSF excretion on both spot collection days. USF 
excretion ranged from 0.07 to 38.1 mg/void for spot day 1 and 0.3 to 82.6 mg/void for 
spot day 2.  
The within and between subject variability calculated for uSF excretion in timed 
spot urine collections (mg/void) and 24-h urine (mg/d) are presented in Table 9. Within-
subject (WS) and between-subject (BS) %CV for uSF in 24-h urine was 38.4% and 
58.3%, respectively. Within-subject variability in uSF was lowest in the afternoon timed 
void (CVWS= 49.1%) and highest in the morning timed void (CVWS=81.8%). Between-
subject variability was lowest in the next day timed void (CVBS= 103.4%) and highest in 
the evening timed void (CVBS=138.9%). The ratio of within to between subject variance 
of uSF excretion (varws/varbs) was 1.3 for 24-h urine, and it ranged from 0.2 for the 
afternoon timed void to 2.9 for the morning timed void (Table 9). 
Table 9: Variability estimates for two-day mean sum of sucrose and fructose excretion 
(uSF) in 24 hour urine (mg/day) and time spot urine collections (mg/void) made 
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during multiple spot urine collection day 1 and 2 (n=14) 
 %CVWS VarWS %CVBS VarBS 
VarWS / 
VarBS 
uSF in 24h 
urine 38.4 1170.4 58.3 868.3 1.3 
uSF in 
morning void  81.8 458.8 104.9 157.9 2.9 
uSF in 
afternoon void  49.1 18.9 125.6 96.8 0.2 
uSF in evening  
void  60.5 273.2 138.9 158.4 1.7 
uSF in next 
day void  65.8 49.6 103.4 85.0 0.6 
%CVWS: Within-subject coefficient of variation; %CVBS : Between-subject coefficient of 
variation; VarWS: Within-subject variance; VarBS: Between-subject variance 
 
The within and between subject variability for uSF excretion (mg/g creatinine) 
have been reported in Table 10. Within-subject variability in uSF excretion (mg/g 
creatinine) was lowest in the afternoon timed void (CVWS= 49.6%) and highest in the 
morning timed void (CVWS=73.3%). Between-subject variability in uSF excretion (mg/g 
creatinine) was lowest in the morning timed void (CVBS= 66.3%) and highest in the 
afternoon timed void (CVBS=111.4%). The ratio of within to between subject variance for 
excretion mg/g creatinine for the timed spot collections ranged from 0.3 for the afternoon 
timed void to 2.5 morning timed void. 
Table 10: Variability estimates for two-day mean sum of sucrose and fructose excretion 
(uSF) in time spot urine collections (mg/g creatinine) made during multiple spot urine 
collection day 1 and 2 (n=14) 
 %CVWS VarWS %CVBS VarBS 
VarWS / 
VarBS 
uSF in morning 
void  73.3 3913.6 66.3 1588.6 2.5 
uSF in 
afternoon void  49.6 767.5 111.4 2408.0 0.3 
uSF in evening  
void  62.7 2460.3 82.3 1053.9 2.3 
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uSF in next 
day void  60.0 149.5 94.5 327.1 0.5 
%CVWS: Within-subject coefficient of variation; %CVBS: Between-subject coefficient of 
variation; VarWS: Within-subject variance; VarBS: Between-subject variance 
 
Table 11 and 12 present the correlation coefficients for the association between 
uSF excretion in 24-h urine and timed urine voids in mg/void (Table 11) or mg/g 
creatinine (Table 12).   
Table 11: Correlation between the sum of sucrose and fructose excretion (uSF) in timed 
urine voids (mg/void) and 24-h urine collection (mg/day) 
 
 Spot day 1 Spot day 2 2-day means 
 n  r* p value  n  r* p value  r* p value 
uSF in morning 
void vs. 24-h 
urine   
14  0.76 0.002 11  0.70 0.017 0.80 0.001 
uSF in afternoon 
void vs. 24-h 
urine  
14  0.79 0.001 11  0.69 0.020 0.72 0.004 
uSF in evening 
void vs. 24-h 
urine 
14  0.45 0.103 12  0.69 0.013 0.65 0.011 
uSF in next day 
void vs. 24-h 
urine 
14  0.67 0.009 12  0.42 0.173 0.58 0.029 
*Pearson Correlation Coefficient 
 
The two-day mean uSF excretion in all four timed urine voids was statistically 
significantly correlated with 24-h uSF excretion.  The two-day mean uSF excretion in 
morning timed spot showed the strongest correlation with 24-h uSF excretion (mg/void: 
r=0.80; p<0.001; mg/g creatinine: r=0.72; p=0.003) followed by the uSF excretion in 
afternoon timed spot (mg/void: r=0.72; p=0.004; mg/g creatinine: r=0.67; p=0.009). 
Correlations based on multiple spot urine collection day 1 and 2 ranged from r=0.42 
(p=0.173) for uSF excretion (mg/void) in the next day void to r=0.79 (p<0.001) for 
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uSF excretion in the afternoon timed void (Table 11). For uSF excretion in mg/g 
creatinine, the correlations based on multiple spot urine collection day 1 and 2 ranged 
from r=0.43 (p=0.158) for uSF excretion (mg/void) in the next day void to r=0.79 
(p=0.002) for uSF excretion (mg/void) in the evening void (Table 12). 
 
Table 12: Correlation between the sum of sucrose and fructose excretion in timed urine 
voids (mg/g creatinine) and 24h urine collection (mg/day)  
 Spot day 1 Spot day 2 2-day means 
 n  r* p value  n  r* p value  r* p value 
uSF in morning 
void vs. 24-h 
urine   
14  0.53 0.053 11 0.60 0.053 0.72 0.003 
uSF in afternoon 
void vs. 24-h 
urine  
14  0.78 0.001 11 0.58 0.063 0.67 0.009 
uSF in evening 
void vs. 24-h 
urine 
14  0.52 0.058 12  0.79 0.002 0.64 0.014 
uSF in next day 
void vs. 24-h 
urine 
14  0.64 0.014 12  0.43 0.158 0.57 0.034 
*Pearson Correlation Coefficient 
 
Table 13 presents findings from various linear regression models with 24-h uSF 
as a dependent variable, using uSF mg/void in timed spot voids as a predictor.  
Table 13: Linear regression models findings from regressing the sum of sucrose and 
fructose excretion (uSF) in 24-h urine (mg/day) on the sum of sucrose and fructose 
excretion (uSF) in timed spot voids (mg/void) along with other covariates for spot day 1, 
spot day 2 and two-day mean 
 Spot day 1 Spot day 2 Two-day mean 
 Beta 
coefficient; 
SE 
p value Beta 
coefficient; 
SE 
p value Beta 
coefficient; 
SE 
p value 
Model 1:   
USF in 
morning void 
12.8; 3.1 0.002 62.0; 16.3 0.005 13.3; 2.9 0.001 
 Gender 
(male) 
- - -38.1; 19.1 0.082 -11.5; 9.8 0.268 
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Adjusted R2 0.54 0.57 0.62 
p value 0.002 0.014 0.002 
Model 2:   
USF in 
afternoon void 
55.2; 11.7 0.001 25.4; 15.0 0.134 50.8; 10.3 0.001 
Age (years) 0.9; 0.6 0.178 1.8; 1.0 0.111 1.7; 0.5 0.010 
Time since 
last meal 
(mins) 
- - 37.5; 18.9 0.088 0.1; 0.1 0.307 
Adjusted R2 0.63 0.64 0.69 
p value 0.002 0.016 0.002 
Model 3:   
USF in 
evening void 
28.0; 12.1 0.043 50.4; 16.7 0.013 33.2; 11.1 0.011 
Age (years) -1.2; 0.8 0.143 - - - - 
Void volume 
(ml) 
-31.0; 23.4 0.214 - - - - 
Adjusted R2 0.30 0.42 0.38 
p value 0.090 0.013 0.011 
Model 4:   
USF in next 
day void 
21.1; 10.2 0.069 28.1; 19.5 0.193 39.3; 11.5 0.008 
Age (years) -1.3; 0.7 0.079 3.9; 1.5 0.30 1.5; 0.6 0.033 
Gender (male) - - -61.4; 29.9 0.079 -31.6; 11.4 0.021 
Time since 
last meal 
(mins) 
-0.1; 0.1 0.048 - - - - 
Void volume 
(ml) 
-0.1; 0.0 0.107 -74.5; 60.8 0.260 -0.1; 0.0 0.021 
Adjusted R2 0.57 0.38 0.63 
p value 0.018 0.122 0.009 
 
Other covariates, including BMI (kg/m2), age (years), gender, void volume (ml), and time 
since last meal (minutes) were investigated. BMI did not improve the predictability of 
any of the models and was therefore not included.  In the linear regression models 
predicting two-day mean 24-h uSF excretion, the model with the afternoon void uSF 
along with age and time since last meal (Table 13; model 2) generated the largest 
adjusted R2 value of 0.69 (p=0.002). The adjusted R2 for the model with the afternoon 
void uSF excretion as the only independent variable was 0.38 (p=0.011). However, 
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adding age and time since last meal significantly improved the predictive ability of the 
final model (adjusted R2 = 0.69; p=0.002).  
 For the remaining two-day mean models, uSF in the morning, evening, and next 
day void were all statistically significant, with adjusted R2 values ranging from 0.38 to 
0.63. Adding gender as a covariate improved the two-day mean model for the morning 
void (Table 13; model 1) from adjusted R2 of 0.47 (p=0.004) to 0.62 (p=0.002). No 
covariates improved the evening void model (Table 13; model 3), whereas adding age, 
gender, and void volume improved the next day void model (Table 13; model 4) from 
adjusted R2 of 0.61 (p=0.001) to 0.63 (p=0.009).  
This trend was similar in spot day 1 and spot day 2 models, with the afternoon 
void uSF excretion being the strongest predictor of 24-h uSF. All models for spot day 1 
and spot day 2 were statistically significant except for the evening void uSF (Table 13; 
model 3) on spot day 1 (R2=0.30, p=0.090) and the next day void (Table 13; model 4) on 
spot day 2 (R2=0.38, p=0.122).  The predictability of the models improved when using 
the two-day mean void compared to single spot voids for morning, afternoon and next 
day void, but not for the evening void. 
Table 14 presents the results from linear regression models ran for 24-h uSF 
using uSF mg/g creatinine in timed spots as predictors.  
 
Table 14: Linear regression models findings from regressing the sum of sucrose and 
fructose excretion (uSF) in 24-h urine (mg/day) on the sum of sucrose and fructose 
excretion (uSF) in timed spot voids (mg/g creatinine) along with other covariates, for spot 
day 1, spot day 2 and two-day mean 
 Spot day 1 Spot day 2 Two-day mean 
 Beta 
coefficient; 
SE 
p 
value 
Beta 
coefficient; 
SE 
p 
value 
Beta 
coefficient; 
SE 
p 
value 
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Model 1:   
USF in 
morning void 
21.3; 10.0 0.053 73.2; 25.0 0.019 0.6; 0.1 0.001 
 Gender 
(male) 
- - -39.9; 22.7 0.117 -19.3; 10.7 0.101 
Void volume 
(ml) 
- - - - 0.1; 0.0 0.123 
Adjusted 
R2 
0.22 0.42 0.58 
p value 0.053 0.047 0.008 
Model 2:   
USF in 
afternoon 
void 
51.4; 12.0 0.001 16.4; 18.5 0.403 46.5; 13.6 0.008 
Age (years) - - 1.4; 1.1 0.251 1.1; 0.6 0.112 
BMI (kg/m2) - - - - 3.9; 2.1 0.104 
Time since 
last meal 
(mins) 
- - 49.4; 19.0 0.035 0.4; 0.2 0.047 
Adjusted 
R2 
0.57 0.55 0.56 
p value 0.001 0.036 0.021 
Model 3:   
USF in 
evening void 
0.8; 0.2 0.005 80.4; 19.7 0.002 43.6; 15.1 0.014 
Age (years) -2.2; 0.8 0.022 - - - - 
Gender 
(male) 
13.7; 13.1 0.321 - - - - 
Adjusted 
R2 
0.46 0.59 0.36 
p value 0.028 0.002 0.014 
Model 4:   
USF in next 
day void 
21.3; 11.5 0.097 25.8; 21.3 0.265 38.7; 13.9 0.021 
Age (years) -1.5; 0.7 0.048 3.7; 1.5 0.043 1.2; 0.7 0.105 
Gender 
(male) 
- - -60.6; 31.1 0.092 -32.4; 12.7 0.031 
Time since 
last meal 
(mins) 
-0.1; 0.1 0.068 - - - - 
Void volume 
(ml) 
-0.1; 0.0 0.112 -63.8; 62.4 0.341 -0.1; 0.0 0.037 
Adjusted 
R2 
0.54 0.33 0.54 
p value 0.024 0.151 0.023 
Other covariates, including BMI (kg/m2), age (years), gender, void volume (ml), and time 
since last meal (minutes) were investigated.  For the two-day mean linear regression 
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models, the morning void uSF (Table 14; model 1) along with gender and void volume 
was the strongest predictor of 24-h uSF with adjusted R2 value of 0.58 (p=0.008). Adding 
these as covariates, strengthened the model from an adjusted R2 of 0.48 (p=0.003) to 0.58 
(p=0.008), and was thus included. 
The remaining two-day mean models (afternoon void, evening void, and next day 
void) were all statistically significant, with adjusted R2 values ranging from 0.36 for the 
evening void to 0.56 for the afternoon void. Age, BMI and time since last meal improved 
the afternoon void model (Table 14; model 2) from adjusted R2 of 0.40 (p=0.009) to 0.56 
(p=0.021). No covariates improved the evening void model (Table 14; model 3). Age, 
gender, and void volume, when added as covariates improved the predictive ability of the 
next day void uSF excretion (Table 14; model 4) from adjusted R2 of 0.35 (p=0.015) to 
0.54 (p=0.023).  
For spot day 1 and spot day 2 models, the adjusted R2 values ranged from 0.22 for 
the morning void to 0.59 for the evening void. All models for spot day 1 and spot day 2 
were statistically significant, except the morning void model (Table 14; model 1) on spot 
day 1 (R2=0.22, p=0.053) and the next day void model (Table 14; model 4) on spot day 2 
(R2=0.33, p=0.151). 
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CHAPTER 5 
DISCUSSION 
The purpose of this analysis was to investigate the utility of sucrose and fructose 
in spot urine as a biomarker of sugars intake in US adults. Previously, two feeding studies 
conducted in the United Kingdom investigated this biomarker in 24-h urine, and found a 
dose-response relationship between total sugars intake and excretion of sucrose and 
fructose, and determined good performance of the biomarker (Tasevska et al., 2005).  
However, high cost, heavy participant burden, and complex logistics associated with 24-h 
urine collections justifies the investigation of this biomarker measured in spot urine. 
Data were collected from 15 participants, age 22 to 49 years, residing in the 
Phoenix Metropolitan Area, who completed a 15-day feeding study in which they 
consumed their normal diet, and collected eight, nonconsecutive, 24-hour urine samples 
(i.e., every other day for 15 days). On two of the eight days, participants collected each 
urine void in a separate container, resulting in a multiple spot urine collection. Data from 
these two urine collection days were analyzed and were the focus of this thesis analyses.  
The mean 24-h sucrose and fructose excretion in our population, while following 
their normal diet provided by the metabolic kitchen, was 50.6 mg/day (SD: 29.5; range: 
5.0 - 110.6 mg/day), which was lower compared to other studies.  In their 13 participants, 
using a similar study design to ours, Tasevska et al. (2005) reported a 30-day mean 24-h 
uSF excretion of 98 mg/day with a range of 25.4 to 267.5 mg/day, which is nearly double 
the excretion level we measured. This implies that the total sugars intake in our study 
population (n=14) was at the lower end of the intake range. 
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Upon analysis of the urine collections, we found that among four timed voids, the 
uSF excretion in the afternoon void - first void collected after lunch or between 12:31-
5:30 pm, had the lowest day-to-day (i.e., within subject) variation and the lowest ratio of 
within to between subject variance. This suggests that less afternoon voids would be 
needed to characterize individuals with regard to their excretion level.  Secondly, two-day 
mean uSF excretion for all four timed urine voids were significantly correlated with 24-h 
uSF excretion, yet the morning and afternoon void exhibited the strongest associations.  
Lastly, all timed voids along with other covariates were found to be significant predictors 
of 24-h uSF excretion. The afternoon void was found to have the strongest predictive 
ability of 24-h uSF excretion when measured in mg/void, especially when age and time 
since last meal were included as covariates in the models explaining 69% of the 
variability in 24-h uSF excretion. In comparison, uSF in the afternoon void expressed in 
mg/g creatinine explained 56% of the variability in 24-h uSF excretion. This suggests that 
creatinine may be introducing an error, and therefore it may be better to use uSF in 
mg/void when possible. 
In the analyses, uSF biomarker was expressed in mg/void and mg/gram 
creatinine, as urinary creatinine is commonly used to adjust biomarker concentrations for 
urine dilution. For example, if a urine sample is significantly diluted, indicating that the 
participant is overly hydrated, or concentrated, indicating dehydration, albeit identical 
amount of the biomarker in the sample, the biomarker concentration measured under 
those two conditions will be very different, and thus it would not reflect the actual 
exposure. While measuring the biomarker in mg/gram creatinine may be advantageous 
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because it corrects for urine volume, meaning the volume of the urine void would not 
need to be known, creatinine may possibly introduce an error. Barr et al. (2005) report 
differences in creatinine excretion by gender, age and race. For example, Non-Hispanic 
blacks compared to all other racial groups, and adult men compared to females had 
significantly greater concentrations of urinary creatinine.  Kidney dysfunction and red 
meat intake can also effect urinary creatinine concentrations, though presence of any 
kidney disease was an exclusion criterion for our study.  While requiring the urine void 
volume to be known makes the utilization of this biomarker in population studies more 
difficult to implement, the risk of creatinine possibly introducing ME may not outweigh 
the benefits of using it.  
We found no statistically significant difference in uSF excretion level (mg/void) 
between any of the timed voids. However, when using uSF excretion per g creatinine, 
there was a statistically significantly higher uSF excretion in the morning compared to 
next day void.  Given our limited sample size, data from more participants are needed to 
gain a better understanding of diurnal variation in uSF excretion.  
Studies of other biomarkers have investigated diurnal variation for these 
biomarkers. In a study with 481 free-living participants, researchers found that the next 
day void had the lowest concentrations (mmol/L) of sodium, potassium, and chloride 
compared to morning, afternoon and evening voids (Wang et al., 2013). The same study 
discovered concentrations of iodine and creatinine to be consistent across the four timed 
voids. Another study investigated urinary creatinine concentrations from participants in 
the third NHANES from 1988-1994 (Barr et al. 2005). They established reference ranges 
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for ages, gender, race/ethnicity, etc., and they reported a small but statistically significant 
increase in creatinine concentrations in the morning compared with the afternoon and 
evening voids. The author discussed that the significant difference could be in part due to 
morning voids being more concentrated, reflecting lengthy overnight periods; however, 
the notion that the significant difference could possibly indicate a diurnal variation should 
not be overlooked (Barr et al., 2005). While a greater sample size is needed to further 
confirm the lack of diurnal variation in the uSF biomarker, even a low variation would 
support the use of spot urines over 24-h urine. 
The first aim of this study was to describe the within-subject (WS) and between-
subject (BS) variability of uSF in 24-hour and multiple spot urine collections, both of 
which are measured as percent coefficient of variation (%CVWS or %CVBS) and as 
variance estimates (VARWS and VARBS). WS variability indicates participant’s day-to-
day variability in uSF excretion. High %CVWS means that a higher number of urine voids 
would be needed to obtain usual uSF excretion level, whereas a low %CVWS suggests 
that individuals’ uSF excretion levels do not vary greatly from day to day, meaning a 
lower number of urine voids would be needed to obtain the usual uSF excretion level 
(Bingham, 2002; Tasevska et al., 2005). BS variability reports the variability in excretion 
between participants. Lower WS than BS variability, notated VARWS/VARBS <1 allows 
researchers to more reliably rank participants according to their excretion level in a 
group, using fewer urine samples. Less urine void collections reduce the participant 
burden and associated cost. 
In our study population, day-to-day variability of uSF excretion based on two 24-
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h urine collection was 38.4%.  Tasevska et al. (2005) investigated 24-h uSF as a 
biomarker in the UK with participants consuming their normal diet and collecting 24-h 
urine daily for 30 days (n=13) and found a similar %CVWS for 24-h uSF (36.9%).  Yet, 
the ratio of WS/BS variance (VARWS/VARBS) in this study was lower (0.49) compared to 
what we found (1.3). This may have been due to the much higher number of repeated 
measurements of 24-h uSF they had (n = 30) allowing them to better characterize 
individuals’ excretion levels within the group.  In another study (n=12), the same 
investigators examined the dose-response of uSF to constant levels of low-sugars (63±5 
g/d, 9.5% of energy intake-EI), medium-sugars diet (143± 5 g/d, 21.8% EI), and high-
sugars diet (264± 3 g/d, 40.2% EI) (Tasevska et al., 2005).  Based on four 24-h urine 
collections per dietary period, they found that the within-subject variability of urinary 
sucrose and urinary fructose to be high in participants while on low sugars diet (%CVWS 
for urinary sucrose = 61.4%; %CVWS for urinary fructose = 60.7%), whereas the %CVWS 
was lower during medium and high sugars diets (%CVWS was approximately 30% for 
urinary sucrose and 20% for urinary fructose).  Although, in the latter study authors 
reported variability estimates separately for urinary sucrose and urinary fructose, this 
suggests that the variability of 24-h uSF excretion is higher at lower levels of excretion. 
However, in our study, participants were not assigned to a constant level of sugars intake, 
rather, they consumed their normal diet with varying levels of intake. Our study found 
uSF excretion in the timed spots to be low (3.6-7.5 mg/void) but the WS variability 
estimates were high (%CVWS = 49.1-81.8%). WS variability was lowest in the afternoon 
timed void (%CVWS = 49.1-49.6%) and highest in the morning timed void (%CVWS = 
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73.3-81.8%) for both uSF mg/void and mg/g creatinine. 
Similar to what was observed for uSF excretion, Wang et al. (2013) found that the 
WS variability of sodium and potassium excretion was lower for the 24-h urine excretion 
than for the timed spot urines. For sodium, 24-h %CVWS was reported to be 19-23%, 
whereas for the timed spot urines, %CVWS ranged from 21-39%. For potassium, 24-h 
%CVWS was reported to be 17%, whereas for the timed spot urines %CVWS ranged from 
22-40%. Ultimately, it appears that the %CVWS variability was highest in the evening 
voids for all of the investigated nutrients (Na, K, Cl, creatinine, and iodine) ranging from 
28-41%.  
In our study population, we found high BS variability for all the timed spots for 
both uSF mg/void and mg/g creatinine. Yet, the BS variability was higher for uSF 
mg/void (%CVBS range = 103.4-138.9%) than for mg/g creatinine (%CVBS range = 66.3 
– 111.4%).  More importantly, the ratios of VARWS/VARBS ranged from 0.2 to 2.9 for 
uSF mg/void and from 0.3 to 2.5 for mg/g creatinine. Favorable variance ratios were 
identified for afternoon and next day voids for uSF excretion mg/void (0.2 and 0.5, 
respectively) and mg/g creatinine (0.3 and 0.6, respectively). For the morning and 
evening voids, unfavorable VARWS/VARBS >1was noted. Overall, the uSF in the 
afternoon spot from our study was identified to be the most reproducible having had the 
lowest day-to-day variability and high BS variability, resulting in VARWS/VARBS ratios 
of less than one.  In comparison to what we found for uSF, the ratios of within to between 
subject variance for sodium, potassium and chloride were much lower (Wang et al., 
2013); for sodium, the ratio was lowest in the afternoon void among blacks (0.6), and 
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overnight void among other races (0.3); for potassium, in the afternoon void for both 
blacks and other races (0.3); and for chloride, in the morning void for blacks (0.4), and 
the overnight void for other races (0.3). The results for the majority of the timed voids 
were all favorable with ratio <1. This may be due to their larger samples size, and a 
higher number of repeated measurements, or due to the metabolic turnover rate of the 
nutrients themselves. 
The second aim was to investigate the correlation of uSF excretion in spot urine 
with the corresponding 24-h excretion. All timed void uSF excretion levels were 
significantly correlated with 24-h uSF excretion. The strongest associations were found in 
the morning (r= 0.80) and the afternoon void (r=0.72) for mg/void, and for mg/g 
creatinine (r=0.72 and r=0.67, respectively). While the morning timed void was identified 
as having the strongest association with 24-h uSF excretion, the unfavorable 
VARWS/VARBS ratio suggests that this void is less reproducible. Given the afternoon 
timed void had a strong association with 24-h uSF excretion and VARWS/VARBS ratio <1, 
it may provide a more reliable estimate of uSF.  Though no other study has compared the 
uSF in spot urine to 24-h uSF excretion, other studies have investigated the correlation 
between spot and 24-h urine of other biomarkers. 
In a study by Patil et al. (2014), participants (n=241) were asked to collect a 24-h 
urine and a random spot sample, either before or after completing the 24-h urine 
collection, which were analyzed for protein and creatinine. The urinary protein to 
creatinine ratio in the random (untimed) spot sample was highly correlated with 24-h 
urine protein (r=0.98, p <0.05).  
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Several other studies have compared the excretion of other analytes in timed spot 
voids to 24-h excretion. A study by Doenyas-Barak et al. (2015) evaluated the use of 
multiple timed spot urine collections as a new method to estimate 24-h urinary sodium, 
potassium and chloride compared to measuring the electrolytes in 24-h urine, i.e., the 
gold standard. Participants consumed their usual diet and collected a 24-h urine and four 
timed 10 ml spot urine collections. Investigators determined the electrolyte to creatinine 
ratio for each timed spot collection, and averaged the electrolyte to creatinine 
concentrations from 2, 3 or 4 timed voids. They then used these values to estimate 24-h 
electrolyte excretion based on the expected creatinine excretion in mg per day. They 
discovered statistically significant correlation between estimated 24-hour urine solute 
excretion (based on a spot measurement) and measured 24-h urinary solute excretions. 
Furthermore, they found that averaging electrolyte-to-creatinine excretion from two to 
four spots rather than using a single spot improved the correlation with measured 24-h 
electrolyte excretion; the correlations for a single spot collection were 0.68, 0.75, and 
0.51, and for the average of 3 spots 0.85, 0.78, and 0.56 for Na, K, and Cl, respectively 
(Doenyas-Barak et al., 2015). They concluded that average sodium and potassium 
concentrations across four scheduled spots may better approximate daily excretion level.   
As these analytes are affected by other variables rather than intake only, collecting 
several spot voids over a 24-h period and averaging the excretion amount can help 
improve estimate 24-h excretion and help reduce diurnal variation.  
In another study, Perrine et al. (2014) investigated the use of spot urine samples to 
estimate iodine status of a population. Four hundred participants collected all the voids 
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over 24-hours, and morning, afternoon, evening, and overnight voids as well as a 24-h 
urine composite were measured for iodine and creatinine.  They investigated excretion 
versus concentration of iodine and explored different equations to estimate 24-h iodine 
excretion from iodine measured in spot urine. They calculated urine iodine concentration 
(UIC) for each time spot sample as well as the iodine-to-creatinine ratio (I/Cr) for each 
spot. They also estimate 24-h urinary iodine excretion (UIE) based on predicted 24-h 
creatinine, and reported no statistically significant difference between estimated and 
observed 24-h UIE (Perrine et al., 2014). Furthermore, they concluded that UIC in spot 
samples can reasonably estimate UIC for 24-h samples, but estimates of UIC, I/Cr, and 
estimated 24-h UIE from spot samples should not be used interchangeably (Perrine et al., 
2014).  
As demonstrated, several analytes (Na, K, I) measured in spot urine samples can 
adequately predict or estimate 24-h excretion using different approaches. While there is 
growing evidence that multiple spot urine collections may be able to serve as a proxy for 
estimating 24-h urine excretion, the protocol for this will be analyte-dependent.  
Lastly, linear regression models were fit to determine the ability of spot void uSF 
to predict 24-h uSF excretion, and how the dependent variable (24-h uSF excretion) 
changes based on the independent variable (uSF in timed spot void). The adjusted R2 
value indicates the percentage of variability in the outcome variable that can be explained 
by the independent variable. The adjusted R2 was considered in the analyses because 
unadjusted estimate may be too optimistic due to multiple predictors in the models and 
the small sample size. The addition of other covariates to these models, including BMI 
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(kg/m2), age (years), void volume (ml), gender, and time since last meal (minutes), were 
investigated to see if they would improve the predictability of the models. These were 
investigated because if these variables improve the prediction of 24-h uSF, then they can 
be used in addition to the spot urine uSF excretion.  
 In all timed spot models, but the evening void, the investigated covariates 
improved the model. USF excretion in the afternoon void along with age and time since 
last meal was the strongest predictor of 24-h uSF excretion, with an adjusted R2 value of 
0.69 (mg/void). This means that nearly 69% of the variability in 24-h uSF excretion can 
be explained by this model. Whereas the morning void had the strongest predictive ability 
for uSF excretion in mg/g creatinine with an adjusted R2 value of 0.58, the afternoon void 
was nearly as strong with an adjusted R2 value of 0.56. Even though the afternoon void 
model did not generate the strongest adjusted R2 for uSF excretion (mg/g creatinine), this 
void had the lowest estimated day-to-day variability and the most favorable 
VARWS/VARBS ratio, which indicates good reproducibility of the measure. We can thus 
assume that this void may be best to use estimate 24-h uSF excretion. Yet, this should be 
further investigated in a larger sample size, and participants with a wide range of sugars 
intake representative of the US diet. 
A study by Robinson Cohen et al. (2014) investigated the precisions and accuracy 
of spot urine phosphate measurements compared to 24-h measurements. Participants 
(n=148) collected 24-h collections and spot urine collections on the same day. They used 
multiple linear regression to explore the effect of various covariates in model prediction 
(age, sex, height, weight, collection time, and last meal time). They found that age, sex, 
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and weight significantly improved the prediction of 24-h urinary phosphate, and 
suggested that this novel equation provides a reasonable estimate of 24-h phosphate 
excretion that can be used for clinical purposes and future research studies. 
This highly controlled feeding study designed to mimic participants’ habitual diet 
was the first of its kind to investigate the utility of uSF biomarker in spot urine.  
Participants maintained their body weight throughout the feeding period implying that 
they were in energy balance, which is essential for investigating performance of dietary 
biomarkers.  Another strength of this analysis is that we were able to assess completeness 
of 24-h urine collections using the PABA marker. Complete collections are essential 
when measuring urinary biomarkers, as any missing urine could introduce bias in 
biomarker estimates (Bingham, 2002).  Lastly, multiple spot urine collections were made 
on two days of the 15-day feeding period, which allowed us to assess day-to-day 
variability in uSF excretion in the identified timed spot voids.  One of the major 
limitations of our analysis is the small samples size, which may have led to 
overestimation of the within subject and between subject variability estimates for uSF in 
timed spot voids. Additionally, dietary data were not available for this analysis, hence 24-
h uSF excretion was used as a surrogate measure of total sugars intake. As a next step, 
the utility of uSF in spot urine needs to be investigated against true sugars intake.  
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CHAPTER 6 
CONCLUSION 
In this highly controlled feeding study investigating the utility of spot urine for 
uSF biomarker measurement, uSF in each of the four timed voids (morning, afternoon, 
evening and next day void) was significantly correlated with 24-h uSF excretion. We 
found that uSF in the afternoon timed void had the best reproducibility, and along with 
other covariates, explained the highest proportion of variability in 24-h uSF excretion. 
Due to our limited sample size and limited range of sugars intake in the study population, 
these findings have yet to be confirmed in a larger study. 
While 24-h urine collections are the gold standard for urinary biomarkers, they 
are cumbersome and costly.  The findings of this study suggest that spot urine samples 
can be utilized for sugars biomarker measurement instead of relying on burdensome 24-h 
urine collections. More feasible methods to objectively measure sugars intake can lead to 
better understanding of sugars and disease associations that previously have been difficult 
to establish. 
 
  
   
82 
REFERENCES 
Ainsworth, B. E., Bassett, D. R.,Jr, Strath, S. J., Swartz, A. M., O'Brien, W. L., 
Thompson, R. W., et al. Comparison of three methods for measuring the time spent 
in physical activity. Medicine and Science in Sports and Exercise, 32(9 Suppl) 2000, 
S457-64. 
 
Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., & Pirkle, J. L. 
Urinary creatinine concentrations in the U.S. population: Implications for urinary 
biologic monitoring measurements. Environmental Health Perspectives 
2005; 113(2), 192-200. 
 
Beltsville Human Nutrition Research Center. The U.S. department of Agriculture’s food 
model booklet, FMB. Agricultural Research Service. July 2007. 
 
Bingham, S. A., Cassidy, A., Cole, T. J., et al. Validation of weighed records and other 
methods of dietary assessment using the 24 h urine nitrogen technique and other 
biological markers. The British Journal of Nutrition, 1995; 73(4), 531-550. 
DOI:S0007114595000584  
 
Bingham, S. A., & Cummings, J. H.. The use of 4-aminobenzoic acid as a marker to 
validate the completeness of 24 h urine collections in man. Clinical Science, 1983; 
64(6), 629-635. 
 
Bingham, S. A., & Cummings, J. H.. Urine nitrogen as an independent validatory 
measure of dietary intake: A study of nitrogen balance in individuals consuming 
their normal diet. The American Journal of Clinical Nutrition, 1985; 42(6), 1276-
1289. 
 
Bingham, S., Luben, R., Welch, A., Tasevska, N., Wareham, N., & Khaw, K. T. 
Epidemiologic assessment of sugars consumption using biomarkers: Comparisons of 
Obese and Nonobese Individuals in the European Prospective Investigation of 
Cancer Norfolk. Cancer Epidemiol Biomarkers Prev, 2007; 16: 1651-1654.  
 
Bingham, S. A. Biomarkers in nutritional epidemiology. Public Health Nutrition, 2002; 
5(6A), 821-827. DOI: 10.1079/PHN2002368. 
 
Bowman, Shanthy A. "Added sugars: Definition and estimation in the USDA Food 
Patterns Equivalents Databases." Journal of Food Composition and Analysis, 2017. 
 
Brody, T.. Digestion and absorption. Nutritional biochemistry (Second edition ed., pp. 
57-131). San Diego USA: Academic Press. 1994. 
 
Ceriello, A., Bortolotti, N., Motz, E., Pieri, C., Marra, M., Tonutti, L., et al. Meal-induced 
oxidative stress and low-density lipoprotein oxidation in diabetes: The 
   
83 
possible role of hyperglycemia. Metabolism: Clinical and Experimental, 
1999; 48(12), 1503-1508. 
 
Cogswell ME, Wang CY, Chen TC, et al. Validity of predictive equations for 24-h 
urinary sodium excretion in adults aged 18-39 y. Am J Clin Nutr. 2013;98(6):1502-
1513. 
 
Cross, A. J., Major, J. M., & Sinha, R. Urinary biomarkers of meat consumption. Cancer 
Epidemiology, Biomarkers & Prevention: A Publication of the American 
Association for Cancer Research, Cosponsored by the American Society of 
Preventive Oncology, 2011; 20(6), 1107-1111. DOI:10.1158/1055-9965.EPI-11-
0048. 
 
Cummings, J. H., & Stephen, A. M.. Carbohydrate terminology and classification. 
European Journal of Clinical Nutrition, 2007; 61 Suppl 1, S5-18. DOI:1602936 . 
 
Doenyas-Barak, K., Beberashvili, I., Bar-Chaim, A., Averbukh, Z., Vogel, O., & Efrati, 
S.. Daily sodium and potassium excretion can be estimated by scheduled spot urine 
collections. Nephron, 2015; 130(1), 35-40. DOI:10.1159/000430105. 
 
Erickson, J., Sadeghirad B., Lytvyn L., Slavin J., Johnston BC. The scientific basis of 
guideline recommendations on sugar intake: A systematic review. Annals of Internal 
Medicine, 2016; DOI:10.7326/M16-2020. 
 
Erickson, J., & Slavin, J.. Total, added, and free sugars: Are restrictive guidelines 
science-based or achievable? Nutrients, 2015; 7(4), 2866-2878. DOI: 
10.3390/nu7042866. 
 
Ervin, R. B., & Ogden, C. L.. Consumption of added sugars among U.S. adults, 2005-
2010. NCHS Data Brief, 2013; (122)(122), 1-8.  
 
Freedman, L.S., Kipnis, V., Schatzkin, A., Tasevska, N., Potischman, N. Can we use 
biomarkers in combination with self-reports to strengthen the analysis of nutritional 
epidemiologic studies? Epidemiol Perspect Innov. 2010;7(1):2-5573-7-2. 
 
Freedman, L.S., Schatzkin, A., Midthune, D., Kipnis, V. Dealing with dietary 
measurement error in nutritional cohort studies. J Natl Cancer Inst. 
2011;103(14):1086-1092. 
 
Freedman, L. S., Tasevska, N., Kipnis, V., Schatzkin, A., Mares, J., Tinker, L., & 
Potischman, N.. Gains in statistical power from using a dietary biomarker in 
combination with self-reported intake to strengthen the analysis of a diet-disease 
association. American Journal of Epidemiology, 2010; 172(7), 836-842. 
DOI:10.1093/aje/kwq194. 
 
   
84 
Freeman, R.. Moderate evidence support a relationship between sugar intake and dental 
caries. Evidence-Based Dentistry, 2014; 15(4), 98-99. DOI:10.1038/sj.ebd.6401055. 
 
Freudenheim, J. L., & Marshall, J. R.. The problem of profound mismeasurement and the 
power of epidemiological studies of diet and cancer. Nutrition and Cancer, 
1988; 11(4), 243-250. DOI:10.1080/01635588809513994. 
 
Han, S. Y., Hong, J. W., Noh, J. H., & Kim, D. J.. Association of the estimated 24-h 
urinary sodium excretion with albuminuria in adult koreans: The 2011 korea national 
health and nutrition examination survey. PloS One, 2014; 9(10), e109073. 
DOI:10.1371/journal.pone.0109073. 
 
Han, W., Sun, N., Chen, Y., Wang, H., Xi, Y., & Ma, Z.. Validation of the spot urine in 
evaluating 24-hour sodium excretion in chinese hypertension patients. American 
Journal of Hypertension, 2015; 28(11), 1368-1375. DOI:10.1093/ajh/hpv037. 
 
Hedrick, V. E., Dietrich, A. M., Estabrooks, P. A., Savla, J., Serrano, E., & Davy, B. M.. 
Dietary biomarkers: Advances, limitations and future directions. Nutrition 
Journal, 2012; 11, 109-2891-11-109. DOI:10.1186/1475-2891-11-109. 
 
Hess, J., Latulippe, M. E., Ayoob, K., & Slavin, J. The confusing world of dietary sugars: 
Definitions, intakes, food sources and international dietary recommendations. Food 
& Function, 2012; 3(5), 477-486. DOI:10.1039/c2fo10250a. 
 
 “IFIC Foundation” International Food Information Council. (24 August, 2016). 
Retrieved from <http://www.foodinsight.org/> 
 
Institute of Medicine, Food and Nutrition Board (IOM). Dietary Reference Intakes for 
Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino 
Acids, National Academies Press, Washington, DC, 2002.  
 
Jakobsen, J., Ovesen, L., Fagt, S., & Pedersen, A. N. Para-aminobenzoic acid used as a 
marker for completeness of 24 hour urine: Assessment of control limits for a specific 
HPLC method. European Journal of Clinical Nutrition, 1997; 51(8), 514-519. 
 
Jakobsen J, Pedersen AN, Ovesen L. Para-aminobenzoic acid (PABA) used as a marker 
for completeness of 24 h urine: effects of age and dosage scheduling. Eur J Clin Nutr 
2003; 57: 138–142. 
 
Jenab, M., Slimani, N., Bictash, M., Ferrari, P., & Bingham, S. A.. Biomarkers in 
nutritional epidemiology: Applications, needs and new horizons. Human Genetics, 
2009; 125(5-6), 507-525. DOI:10.1007/s00439-009-0662-5. 
 
Johnson, I.T., Southgate, D.A., Durnin, J.V. Intrinsic and non-milk extrinsic sugars: does 
   
85 
the distinction have analytical or physiological validity? Int J Food Sci Nutr 
1996;47(2):131-40. 
 
Johnson, R., Appel, L., & Brands M, e. a.. Dietary sugars intake and cardiovascular 
health: A scientific statement from the american heart association. Circulation, 
2009; 120(11):1011-1020. 
 
Johnson, R. J., Segal, M. S., Sautin, Y., Nakagawa, T., Feig, D. I., Kang, D. H., . . . 
Sanchez-Lozada, L. G.. Potential role of sugar (fructose) in the epidemic of 
hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and 
cardiovascular disease. The American Journal of Clinical Nutrition, 2007; 86(4), 
899-906. DOI:86/4/899. 
 
Kaaks, R., & Lukanova, A. Energy balance and cancer: The role of insulin and insulin-
like growth factor-I. The Proceedings of the Nutrition Society, 2001; 60(1), 91-106. 
DOI:S002966510100012X. 
 
Kaaks, R., Riboli, E., & Sinha, R. Biochemical markers of dietary intake. IARC 
Scientific Publications, 1997; (142)(142), 103-126. 
 
Kawabata, H., Meddings, J. B., Uchida, Y., Matsuda, K., Sasahara, K., & Nishioka, M.. 
Sucrose permeability as a means of detecting diseases of the upper digestive tract. 
Journal of Gastroenterology and Hepatology, 1998; 13(10), 1002-1006.  
 
Key, T. J., Allen, N. E., Spencer, E. A., & Travis, R. C.. The effect of diet on risk of 
cancer. Lancet, 2002; 360(9336), 861-868. DOI:S0140-6736(02)09958-0. 
 
Kipnis, V., Subar, A. F., Midthune, D., Freedman, L. S., Ballard-Barbash, R., Troiano, R. 
P., Carroll, R. J.. Structure of dietary measurement error: Results of the OPEN 
biomarker study. American Journal of Epidemiology, 2003; 158(1), 14-21; 
discussion 22-6.  
 
Krebs-Smith, S. M., Graubard, B. I., Kahle, L. L., Subar, A. F., Cleveland, L. E., & 
Ballard-Barbash, R.. Low energy reporters vs others: A comparison of reported food 
intakes. European Journal of Clinical Nutrition, 2000; 54(4), 281-287. 
 
Kuhnle, G. G., Joosen, A. M., Wood, T. R., Runswick, S. A., Griffin, J. L., & Bingham, 
S. A.. Detection and quantification of sucrose as dietary biomarker using gas 
chromatography and liquid chromatography with mass spectrometry. Rapid 
Communications in Mass Spectrometry, 2008; RCM, 22(3), 279-282. 
DOI:10.1002/rcm.3355. 
 
Lara, J. J., Scott, J. A., & Lean, M. E. Intentional mis-reporting of food consumption and 
its relationship with body mass index and psychological scores in women. Journal of 
Human Nutrition and Dietetics, 2004; 17(3), 209-218. DOI:10.1111/j.1365-
   
86 
277X.2004.00520. 
 
Lean, M. E., & Te Morenga, L. Sugar and type 2 diabetes. British Medical Bulletin, 
2016; 120(1), 43-53. DOI:ldw037. 
 
Luceri, C., Caderni, G., Lodovici, M., Spagnesi, M. T., Monserrat, C., Lancioni, L., & 
Dolara, P.. Urinary excretion of sucrose and fructose as a predictor of sucrose intake 
in dietary intervention studies. Cancer Epidemiol Biomarkers Prev 1996; 5(3), 167-
171.  
 
Mann, J., & Truswell, S.. Essentials of human nutrition (Third Edition ed.). New York, 
United States: Oxford University Press. 2007. 
 
McCance and Widdowson. Food standards agency, research IoF. McCance and 
widdowson's the composition of foods.  (6th summary ed.). Cambridge: Royal 
Society of Chemistry, 2002. 
 
Nakamura, H., & Tamura, Z.. Gas chromatographic analysis of mono- and disaccharides 
in human blood and urine after oral administration of disaccharides. Clinica Chimica 
Acta, 1972; International Journal of Clinical Chemistry, 39(2), 367-381.  
 
“National Health and Nutrition Examination Survey.” National Center for Health 
Statistics, Centers for Disease Control and Prevention, 2017; 
www.cdc.gov/nhanes/index.htm. 
 
Newens, K. J., & Walton, J.. A review of sugar consumption from nationally 
representative dietary surveys across the world. Journal of Human Nutrition and 
Dietetics : The Official Journal of the British Dietetic Association, 2016; 29(2), 225-
240. DOI:10.1111/jhn.12338. 
 
Park, S., Thompson, F. E., McGuire, L. C., Pan, L., Galuska, D. A., & Blanck, H. M. 
Sociodemographic and behavioral factors associated with added sugars intake among 
US adults. Journal of the Academy of Nutrition and Dietetics, 2016; 116(10), 1589-
1598. DOI:10.1016/j.jand.2016.04.012. 
 
Patil, P., Shah, V., & Shah, B.. Comparison of spot urine protein creatinine ratio with 24 
hour urine protein for estimation of proteinuria. The Journal of the Association of 
Physicians of India, 2014; 62(5), 406-410.  
 
Perrine, C. G., Cogswell, M. E., Swanson, C. A., Sullivan, K. M., Chen, T. C., 
Carriquiry, A. L., et al. Comparison of population iodine estimates from 24-hour 
urine and timed-spot urine samples. Thyroid : Official Journal of the American 
Thyroid Association, 2014; 24(4), 748-757. DOI:10.1089/thy.2013.0404. 
 
Powell, E. S., Smith-Taillie, L. P., & Popkin, B. M.. Added sugars intake across 
   
87 
the distribution of US children and adult consumers: 1977-2012. Journal of the 
Academy of Nutrition and Dietetics, 2016; 116(10), 1543-1550.e1. 
DOI:10.1016/j.jand.2016.06.003.  
 
Prentice, R. L., Mossavar-Rahmani, Y., Huang, Y., Van Horn, L., Beresford, S. A., Caan, 
B., et al. Evaluation and comparison of food records, recalls, and frequencies for 
energy and protein assessment by using recovery biomarkers. American Journal of 
Epidemiology, 2011; 174(5), 591-603. DOI:10.1093/aje/kwr140. 
 
Price, G. M., Paul, A. A., Cole, T. J., & Wadsworth, M. E.. Characteristics of the low-
energy reporters in a longitudinal national dietary survey. The British Journal of 
Nutrition, 1997; 77(6), 833-851. DOI:S0007114597000846. 
 
Renehan, A. G., Zwahlen, M., & Egger, M. Adiposity and cancer risk: New mechanistic 
insights from epidemiology. Nature Reviews.Cancer, 2015; 15(8), 484-498. 
DOI:10.1038/nrc3967. 
 
Robinson-Cohen, C., Ix, J. H., Smits, G., Persky, M., Chertow, G. M., Block, G. A., & 
Kestenbaum, B. R.. Estimation of 24-hour urine phosphate excretion from spot urine 
collection: Development of a predictive equation. Journal of Renal Nutrition, 
2014; 24(3), 194-199. DOI:10.1053/j.jrn.2014.02.001. 
 
Schoeller, D. A. Recent advances from application of doubly labeled water to 
measurement of human energy expenditure. The Journal of Nutrition, 1999; 129(10), 
1765-1768. 
 
Sharma, R. S., Joy, R. C., Boushey, C. J., Ferruzzi, M. G., Leonov, A. P., & McCrory, M. 
A. Effects of para-aminobenzoic acid (PABA) form and administration mode on 
PABA recovery in 24-hour urine collections. Journal of the Academy of Nutrition 
and Dietetics 2014; 114(3), 457-463. DOI:10.1016/j.jand.2013.07.045. 
 
Subar, A. F., Kipnis, V., Troiano, R. P., Midthune, D., Schoeller, D. A., Bingham, et al. 
Using intake biomarkers to evaluate the extent of dietary misreporting in a large 
sample of adults: The OPEN study. American Journal of Epidemiology, 2003; 
158(1), 1-13.  
 
Tasevska, N., Midthune, D., Potischman, N., Subar, A. F., Cross, A. J., Bingham, S. A.. 
Use of the predictive sugars biomarker to evaluate self-reported total sugars intake in 
the observing protein and energy nutrition (OPEN) study. Cancer Epidemiol 
Biomarkers Preven 2011; 20(3), 490-500. DOI:10.1158/1055-9965.EPI-10-0820. 
 
Tasevska, N., Runswick, S. A., & Bingham, S. A. Urinary potassium is as reliable as 
urinary nitrogen for use as a recovery biomarker in dietary studies of free living 
individuals. The Journal of Nutrition, 2006; 136(5), 1334-1340. DOI:136/5/1334. 
 
   
88 
Tasevska, N., Runswick, S. A., McTaggart, A., & Bingham, S. A. Urinary sucrose and 
fructose as biomarkers for sugar consumption. Cancer Epidemiol Biomarkers Preven 
2005; 14(5), 1287-1294. DOI:14/5/1287. 
 
Tasevska, N. Urinary sugars-A biomarker of total sugars intake. Nutrients, 2015; 7(7), 
5816-5833. DOI:10.3390/nu7075255. 
 
Te Morenga, L., Mallard, S., & Mann, J.. Dietary sugars and body weight: Systematic 
review and meta-analyses of randomised controlled trials and cohort studies. BMJ 
(Clinical Research Ed.), 2012; 346, e7492. DOI:10.1136/bmj.e7492. 
 
Te Morenga, L. A., Howatson, A. J., Jones, R. M., & Mann, J.. Dietary sugars and 
cardiometabolic risk: Systematic review and meta-analyses of randomized controlled 
trials of the effects on blood pressure and lipids. The American Journal of Clinical 
Nutrition, 2014; 100(1), 65-79. DOI:10.3945/ajcn.113.081521. 
 
Thompson, F.E., Subar, A.F. Dietary assessment methodology. in: A.M. Coulston, C.J. 
Boushey, M.G. Ferruzzi (Eds.) Nutrition in the prevention and treatment of 
disease. 3rd ed. Academic Press, New York, 2012:5–46. 
 
Tooze, J. A., Subar, A. F., Thompson, F. E., Troiano, R., Schatzkin, A., & Kipnis, V.. 
Psychosocial predictors of energy underreporting in a large doubly labeled water 
study.The American Journal of Clinical Nutrition, 2004; 79(5), 795-804. 
 
University of Minnesota, Nutrition Coordinating Center (NCC). Food and Nutrient 
Database. Nutrient Completeness. Internet: 
http://www.ncc.umn.edu/products/databasenutrientcompleteness2.html. (accessed 
2017).  
 
US Department of Agriculture. USDA National Nutrient Database for Standard 
Reference, Release 27. Agricultural Research Service; 2014. Internet: 
http://www.ars.usda.gov/Services/docs.htm?docid=8964  
 
US Department of Agriculture and US Department of Health and Human Services. 
Dietary Guidelines for Americans, 2010. 7th ed. Washington, DC: US Government 
Printing Office, 2010.  
 
US Department of Health & Human Services and USDA. 2016. New dietary guidelines 
to encourage healthy eating patterns to prevent chronic diseases. 
 
Vos, M. B., Kaar, J. L., Welsh, J. A., Van Horn, L. V., Feig, D. I., Anderson, C. A. 
Added sugars and cardiovascular disease risk in children: A scientific statement from 
the american heart association. Circulation, 2016; 134:00-00. 
DOI:CIR.0000000000000439. 
 
   
89 
Wang, C. Y., Carriquiry, A. L., Chen, T. C., Loria, C. M., Pfeiffer, C. M., Liu, K., et al. 
Estimating the population distribution of usual 24-hour sodium excretion from timed 
urine void specimens using a statistical approach accounting for correlated 
measurement errors. The Journal of Nutrition, 2015; 145(5), 1017-1024. 
DOI:10.3945/jn.114.206250. 
 
Wang, C. Y., Cogswell, M. E., Loria, C. M., Chen, T. C., Pfeiffer, C. M., Swanson, C. et 
al. Urinary excretion of sodium, potassium, and chloride, but not iodine, varies by 
timing of collection in a 24-hour calibration study. The Journal of Nutrition, 2013; 
143(8), 1276-1282. DOI:10.3945/jn.113.175927. 
 
Willet, W. Nutritional epidemiology (3rd ed.). United States of America: Oxford 
University Press. 2012. 
 
Wittekind, Anna, & Walton, Janette. Worldwide trends in dietary sugars intake. Nutrition 
Research Reviews, 2014; DOI: 10.1017/S0954422414000237. 
 
World Health Organization. Guideline: Sugars intake for adults and children. 2015. ISBN 
978 92 4 154902 8. 
 
Yang, Q., Zhang, Z., Gregg, E. W., Flanders, W. D., Merritt, R., & Hu, F. B. Added 
sugar intake and cardiovascular diseases mortality among US adults. JAMA Internal 
Medicine, 2014; 174(4), 516-524. DOI:10.1001/jamainternmed.2013.13563. 
 
   
90 
 
APPENDIX A  
IRB APPROVAL FORM
   
91 
 
   
92 
 
   
93 
 
   
94 
 
APPENDIX B  
RECRUITMENT FLYER 
   
95 
 
 
  
 
 
 
 
 
ARIZONA STATE 
UNIVERSITY 
425 N 5rd Street  
Phoenix, AZ 85004 
www.Sugarsbio.org  
602-827-2545 
Sugarsbio@asu.edu 
 
 
 
 
 
 
 
 
Want to earn $599?  
  Bored with cooking for yourself?    
  Are you healthy and 18-70 years old? 
Then, we need your help for a 15-day feeding study conducted by 
ASU researchers.  You will be consuming your “usual” diet and 
all meals will be provided for you.  Participation is voluntary.   
If you are interested, please call, email or check our website! 
Investigation of Biomarkers for Sugars Intake 
S u garsb io@
asu.e d u 
602-827-254 5 
ww w.S ugarsbio .org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
Sugarsbio@
asu.edu 
602-827-2545 
www.Sugarsbio.org  
 
 
   
96 
APPENDIX C  
SCREENING QUESTIONAIRE  
   
97 
 
   
98 
   
99 
   
100 
 
   
101 
   
102 
APPENDIX D 
INFORMATION SHEET 
 
   
103 
   
104 
   
105 
 
   
106 
APPENDIX E 
CONSENT FORM 
   
107 
 
 
   
108 
 
   
109 
 
 
   
110 
   
111 
 
   
112 
 
   
113 
 
APPENDIX F  
STUDY FIGURE 
   
114 
 
 
   
115 
APPENDIX G  
BASELINE QUESTIONAIRE  
   
116 
 
   
117 
 
   
118 
 
   
119 
 
   
120 
 
   
121 
 
   
122 
 
   
123 
 
   
124 
 
 
   
125 
APPENDIX H  
FOOD DIARY 
   
126 
 
   
127 
 
   
128 
 
   
129 
 
   
130 
   
131 
   
132 
APPENDIX I  
MEAL CHECKLIST 
   
133 
 
   
134 
 
   
135 
   
136 
APPENDIX J  
PHYSICAL ACTIVITY LOG 
   
137 
 
   
138 
 
   
139 
   
140 
 
APPENDIX K  
DIRECTIONS FOR COLLECTING 24-HOUR URINE SAMPLE 
   
141 
 
   
142 
 
   
143 
 
   
144 
 
   
145 
APPENDIX L  
24-HOUR URINE COLLECTION LOG 
   
146 
 
   
147 
 
   
148 
APPENDIX M 
DIRECTIONS FOR COLLECTING MULTIPLE SPOT URINE SAMPLE 
   
149 
 
   
150 
 
   
151 
 
   
152 
 
   
153 
 
   
154 
APPENDIX N  
MULTIPLE SPOT URINE COLLECTION LOG 
   
155 
 
   
156 
 
   
157 
 
   
158 
  
APPENDIX O  
COLORIMETRIC ENZYMATIC ASSAY PROCEDURE 
   
159 
 
   
160 
 
   
161 
 
   
162 
 
   
163 
 
   
164 
 
   
165 
APPENDIX P  
URINARY SUCROSE AND FRUCTOSE (mg/void) BY VOID IN MULTIPLE SPOT 
URINE DAY 1 AND 2 BY PARTICIPANT 
   
166 
 
 
 
   
167 
 
 
   
168 
 
   
169 
 
   
170 
 
 
 
